<!--?xml version="1.0" encoding="UTF-8"?--><doc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" zoom="100" apt_id="1" id="doc_1"><mdata projectname="OUP" category="NARMME" apt_id="2" id="mdata_2"><mta name="article-type" apt_id="3" id="mta_3">research-article</mta><mta name="publisher-id" apt_id="4" id="mta_4">ugaf011</mta><mta name="category-oup-series" apt_id="5" id="mta_5">NA</mta><mta name="category-subject-doi" apt_id="6" id="mta_6">NA</mta><mta name="category-taxonomy-collection" apt_id="7" id="mta_7">NA</mta><mta name="category-taxonomy-collection1" apt_id="8" id="mta_8">NA</mta><mta name="doi" apt_id="9" id="mta_9">10.1093/narmme/ugaf011</mta><mta name="supplementary-material-label" id="mta_10" apt_id="10">Graphical Abstract Figure.</mta><mta name="supplementary-material-caption" apt_id="11" id="mta_11">bbbbbbbbbbbbb</mta><mta name="supplementary-material-graphic" label="image" apt_id="12" id="mta_12">ugaf011_gra.jpg</mta><mta name="pub-date-ppub" apt_id="13" id="mta_13">00-00-2025</mta><mta name="pub-date-epub" apt_id="14" id="mta_14">00-00-2025</mta><mta name="pub-date-collection" apt_id="15" id="mta_15">00-00-2025</mta><mta name="cover-date" apt_id="16" id="mta_16">00-2025</mta><mta name="volume" apt_id="17" id="mta_17">0</mta><mta name="issue" apt_id="18" id="mta_18">0</mta><mta name="fpage" apt_id="19" id="mta_19">1</mta><mta name="lpage" apt_id="20" id="mta_20">0</mta><mta name="elocation-id" apt_id="21" id="mta_21">00</mta><mta name="copyright-statement" apt_id="22" id="mta_22">© The Author(s) 2025. Published by Oxford University Press on behalf of NAR Molecular Medicine.<!--?break ?-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</mta><mta name="copyright-year" apt_id="23" id="mta_23">2025</mta><mta name="corrected-typeset" apt_id="24" id="mta_24">DD-MM-YYYY</mta><mta name="meta-name" exinfo="M1" apt_id="25" id="mta_25">edited-state</mta><mta name="meta-value" apt_id="26" id="mta_26">corrected-proof</mta><mta name="meta-name" exinfo="M2" apt_id="27" id="mta_27">article-lifecycle</mta><mta name="meta-value" apt_id="28" id="mta_28">PAP</mta><mta name="self-uri" exinfo="" apt_id="29" id="mta_29">ugaf011.pdf</mta><mta name="feature-fig-label-1" apt_id="30" id="mta_30">NA</mta><mta name="feature-fig-image-1" exinfo="IMG" apt_id="31" id="mta_31">NA</mta><mta name="feature-fig-label-2" apt_id="32" id="mta_32">NA</mta><mta name="feature-fig-image-2" exinfo="IMG" apt_id="33" id="mta_33">NA</mta><mta name="feature-fig-label-3" apt_id="34" id="mta_34">NA</mta><mta name="feature-fig-image-3" exinfo="IMG" apt_id="35" id="mta_35">NA</mta><mta name="source-wc" apt_id="36" id="mta_36">500</mta><mta name="non-printing-chars" apt_id="37" id="mta_37">false</mta><mta name="display-buttons" apt_id="38" id="mta_38">true</mta></mdata><fm apt_id="39" id="fm_39"><lrh title="Left Running Head" apt_id="40" id="lrh_40">Halmai<query><button type="button" title="Copy Editor to Author-AU: CE: Please provide the short title for running head." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="1" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">1</span></button></query> <i apt_id="43" id="i_43">et al</i><query><button type="button" title="Copy Editor to Author-AU: CE: Please match the article title with the source file in order to avoid any unnecessary changes at the previous stage. Kindly remove this query post validation." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="2" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">2</span></button></query><i apt_id="46" id="i_46">.</i></lrh><rrh title="Right Running Head" apt_id="47" id="rrh_47"></rrh><dochead title="Doc Head" apt_id="48" id="dochead_48">Standard Article</dochead><ti title="Document Title" apt_id="49" id="ti_49">A modular CRISPRa system for molecular therapy of <i apt_id="50" id="i_50">FOXG1</i> syndrome<query><button type="button" title="Copy Editor to Author-AU: If your manuscript has figures or text from other sources, please ensure you have permission from the copyright holder. Also ensure that the copyright owner is properly credited, for instance in the figure legends. Make any changes directly in the text. For any questions about permissions, contact jnls.author.support@oup.com." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="3" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">3</span></button></query><query><button type="button" title="Copy Editor to Author-AU: CE: It is mandatory to insert a query for the author if any grammatical and stylistic changes are made in the title of the paper. Please insert an author query for the changes made in the title." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="4" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">4</span></button></query> </ti><aug title="Authors" sep=", " lsep="" apt_id="55" id="aug_55"><au suffix="1,2,3,†" rid="87 95 99 128" orcid="https://orcid.org/0000-0002-2642-0367" apt_id="56" id="au_56"><f title="First name" apt_id="57" id="f_57">Julian A.N.M.</f><s title="Surname" apt_id="58" id="s_58">Halmai</s></au><au suffix="1,2,3,†" rid="87 95 99 128" apt_id="59" id="au_59"><f title="First name" apt_id="60" id="f_60">Casiana E.</f><s title="Surname" apt_id="61" id="s_61">Gonzalez</s></au><au suffix="1,2,3" rid="87 95 99" apt_id="62" id="au_62"><f title="First name" apt_id="63" id="f_63">Peter</f><s title="Surname" apt_id="64" id="s_64">Deng</s></au><au suffix="1,2,3" rid="87 95 99" apt_id="65" id="au_65"><f title="First name" apt_id="66" id="f_66">Jasmine L.</f><s title="Surname" apt_id="67" id="s_67">Carter</s></au><au suffix="1,2,3" rid="87 95 99" apt_id="68" id="au_68"><f title="First name" apt_id="69" id="f_69">Jennifer J.</f><s title="Surname" apt_id="70" id="s_70">Waldo</s></au><au suffix="1,2,3" rid="87 95 99" apt_id="71" id="au_71"><f title="First name" apt_id="72" id="f_72">David L.</f><s title="Surname" apt_id="73" id="s_73">Cameron</s></au><au suffix="4" rid="106" apt_id="74" id="au_74"><f title="First name" apt_id="75" id="f_75">Angels</f><s title="Surname" apt_id="76" id="s_76">Almenar-Queralt</s></au><au suffix="5" rid="112" apt_id="77" id="au_77"><f title="First name" apt_id="78" id="f_78">Lauro Thiago</f><s title="Surname" apt_id="79" id="s_79">Turaça</s></au><au suffix="4,5" rid="106 112" apt_id="80" id="au_80"><f title="First name" apt_id="81" id="f_81">Alysson R.</f><s title="Surname" apt_id="82" id="s_82">Muotri</s></au><au suffix="1,2,3,*" rid="87 95 99 121" orcid="https://orcid.org/0000-0002-0235-5038" apt_id="83" id="au_83"><f title="First name" apt_id="84" id="f_84">Kyle D.</f><s title="Surname" apt_id="85" id="s_85">Fink</s></au></aug><affg type="arabic" apt_id="86" id="affg_86"><aff id="aff_87" sno="1" type="arabic" apt_id="87"><org title="Organization" apt_id="88" id="org_88">Department of Neurology</org><query><button type="button" title="Copy Editor to Author-AU: Please provide institute/postal code/city/country for affiliation directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="5" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">5</span></button></query><query><button type="button" title="Copy Editor to Author-AU: Please check the spelling and accuracy of all author names and affiliations, particularly for any co-authors. Also check that author surnames are correctly highlighted. This is to ensure that forenames and surnames are tagged correctly for online indexing. Incorrect names and affiliations may lead to an author not being credited for their work by funders, institutions, or other third parties. Make any changes directly in the text. Note that changes to your authorship list (adding or removing authors, changing designation of corresponding author) require additional approvals. Email jnls.author.support@oup.com if this is required." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="6" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">6</span></button></query><query><button type="button" title="Copy Editor to Author-AU: Country was missing. Please check for correctness" contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="7" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">7</span></button></query></aff><aff id="aff_95" sno="2" type="arabic" apt_id="95"><org title="Organization" apt_id="96" id="org_96">MIND Institute</org><query><button type="button" title="Copy Editor to Author-AU: Please provide institute/postal code/city/country for affiliation directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="8" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">8</span></button></query></aff><aff id="aff_99" sno="3" type="arabic" apt_id="99"><org title="Organization" apt_id="100" id="org_100">Stem Cell Program and Gene Therapy Center, University of California Davis Health Systems</org>, <str title="Street" apt_id="101" id="str_101">Sacramento</str>, <str title="Street" apt_id="102" id="str_102">CA</str>, <cny title="Country" apt_id="103" id="cny_103">United States</cny><query><button type="button" title="Copy Editor to Author-AU: Please provide postal code for affiliation directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="9" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">9</span></button></query></aff><aff id="aff_106" sno="4" type="arabic" apt_id="106"><org title="Organization" apt_id="107" id="org_107">Department of Pediatrics and Cellular &amp; Molecular Medicine, School of Medicine, University of California San Diego</org>, <str title="Street" apt_id="108" id="str_108">La Jolla</str>, <str title="Street" apt_id="109" id="str_109">CA</str><str title="Street" apt_id="110" id="str_110">92093</str>, <cny title="Country" apt_id="111" id="cny_111">United States</cny></aff><aff id="aff_112" sno="5" type="arabic" apt_id="112"><org title="Organization" apt_id="113" id="org_113">Integrated Space Stem Cell Orbital Research (ISSCOR) Center, Kavli Institute for Brain and Mind, Center for Academic Research and Training in Anthropogeny (CARTA), Archealization Center (ArchC)</org>, <str title="Street" apt_id="114" id="str_114">La Jolla</str>, <str title="Street" apt_id="115" id="str_115">CA</str><str title="Street" apt_id="116" id="str_116">92093</str>, <cny title="Country" apt_id="117" id="cny_117">United States</cny><query><button type="button" title="Copy Editor to Author-AU: Please provide institute for affiliation directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="10" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">10</span></button></query></aff></affg><coraddg type="symbol" apt_id="120" id="coraddg_120"><coradd title="Cor Address" id="coradd_121" sno="*" type="symbol" apt_id="121">To whom correspondence should be addressed. Kyle D. Fink. Email: <email href="mailto:kdfink@ucdavis.edu" title="e-Mail" apt_id="122" id="email_122">kdfink@ucdavis.edu</email><query><button type="button" title="Copy Editor to Author-AU: CE: phone is missing, please provide." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="11" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">11</span></button></query><query><button type="button" title="Copy Editor to Author-AU: CE: Fax is missing, please provide." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="12" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">12</span></button></query></coradd></coraddg><noteg type="symbol" apt_id="127" id="noteg_127"><note type="symbol" id="note_128" sno="†" apt_id="128">have contributed equally.</note></noteg><hsy title="History" sep=";" id="hsy_129" apt_id="129"><re apt_id="130" id="re_130">October 16, 2024</re><rsd apt_id="131" id="rsd_131">March 27, 2025</rsd><edd apt_id="132" id="edd_132">April 07, 2025</edd><acd apt_id="133" id="acd_133">April 15, 2025</acd></hsy><absg apt_id="134" id="absg_134"><ti title="Abstract Head" apt_id="135" id="ti_135">Abstract</ti>
<p t="fl" title="Paragraph No Indent" apt_id="136" id="p_136">To date, there is an unmet need for novel approaches that address haploinsufficiency disorders in a targeted and robust manner. Here, we developed a novel, modular tool for transcriptional regulation of genes involved in neurodevelopmental disease in the absence of creating double-stranded breaks. We utilized this novel platform technology to identify sgRNAs that efficiently regulate expression of the intellectual disability gene FOXG1 that utilizes an optimized protein intein system. Using a modular assembly of CRISPR trans-activators, including single and dual VP64 dCas9 fusion proteins, sgRNA-mediated MS2 p65 HSF (MPH) recruitment or the addition of the VPR tripartite effector (VP64, p65, Rta) can induce dynamic gene regulation. We further increased mRNA levels of FOXG1 using duplexed sgRNAs paired with different combinations of transcriptional activators. We demonstrate that FOXG1 gene upregulation results in a significant increase in FoxG1 protein translation. Following treatment of mutant FOXG1 neural stem cells with the CRISPR activators, we observed a significant increase in FOXG1 expression with no-off targets as determined by <i apt_id="137" id="i_137">in silico</i> sgRNA binding prediction paired with RNA-sequencing. This approach holds great promise as a modular platform technology that is readily adapted for gene therapy delivery for those affected by rare genetic conditions<query><button type="button" title="Copy Editor to Author-AU: The abstract has been edited as a single paragraph to match journal style. Please edit, if necessary, directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="13" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">13</span></button></query>.<query><button type="button" title="Copy Editor to Author-AU: Please provide a short caption for the graphical abstract." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="14" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">14</span></button></query></p>
</absg><absg exinfo="graphical" apt_id="142" id="absg_142"><ti title="Abstract Head" apt_id="143" id="ti_143">Graphical Abstract</ti><fig id="fig_144" apt_id="144"><ti title="Abstract Head" apt_id="145" id="ti_145"></ti><img src="https://pxeqa.aptaracorp.com/pxestore/assets/pxeoup6qa/NARMME/ugaf011//images/ugaf011_gra.jpg" title="Figure" apt_id="146" id="img_146" /><button class="btn_inline_img noneditable btn btn-info btn-sm" onclick="AptEditorImgManager.initImageManagerButton($(e.target).prev()[0]);" apt_id="147" id="button_147"><i class="fa-solid fa-pen-to-square" apt_id="148" id="i_148"></i></button></fig></absg></fm><bdy apt_id="149" id="bdy_149"><sect1 id="sect1_150" sec-type="intro" apt_id="150"><ti title="Heading 1" apt_id="151" id="ti_151">Introduction</ti>
<p t="fl" title="Paragraph No Indent" apt_id="152" id="p_152">More than 600 genes are estimated to be causative for disease when haploinsufficient [<bibcit rid="461" title="bibcit" href="#" contenteditable="false" id="bibcit_153" sno="1" apt_id="153">1</bibcit>]. Haploinsufficiency (HI) is caused when a single functional allele produces less than normal gene expression that is not sufficient for proper protein and cell function [<bibcit rid="479" title="bibcit" href="#" contenteditable="false" id="bibcit_154" sno="2" apt_id="154">2</bibcit>]. There is an estimate of more than 3 000 genes that are intolerant to loss-of-function, nearly 90% of which are considered HI genes [<bibcit rid="490" title="bibcit" href="#" contenteditable="false" id="bibcit_155" sno="3" apt_id="155">3</bibcit>]. Neurodevelopmental disorders are frequently caused by HI of transcriptional regulator genes (e.g. <i apt_id="156" id="i_156">ARID1B</i>, <i apt_id="157" id="i_157">MED13L</i>, <i apt_id="158" id="i_158">SETBP1</i>, <i apt_id="159" id="i_159">TBR1</i>, <i apt_id="160" id="i_160">CHD8</i>, <i apt_id="161" id="i_161">KMT2C</i>, <i apt_id="162" id="i_162">SETD1A</i>, <i apt_id="163" id="i_163">FOXG1</i>, <i apt_id="164" id="i_164">MEF2C</i>, <i apt_id="165" id="i_165">POU3F2</i>, <i apt_id="166" id="i_166">FOXP2</i>) with many resulting in various syndromes with many morbidities, including intellectual disability (ID), autism spectrum disorders (ASD), schizophrenia, epilepsy, attention deficit hyperactivity disorder (ADHD), bipolar and major depressive as well as speech and language disorders [<bibcit rid="479" title="bibcit" href="#" contenteditable="false" id="bibcit_167" sno="2" apt_id="167">2</bibcit>]. FOXG1 Syndrome is a neurodevelopmental disorder characterized by impaired brain development and function [<bibcit rid="504 523 541" title="bibcit" href="#" contenteditable="false" id="bibcit_168" sno="4 5 6" apt_id="168">4–6</bibcit>]. Phenotypically, children present with seizures, inability to control body movements, and lack of speech [<bibcit rid="523" title="bibcit" href="#" contenteditable="false" id="bibcit_169" sno="5" apt_id="169">5</bibcit>]. Children with haploinsufficient <i apt_id="170" id="i_170">FOXG1</i> have microcephaly, sleep disturbances, inability to sit or walk without assistance, near absence of speech and language skills, limited purposeful use of hands, and present on the Autism Spectrum [<bibcit rid="523" title="bibcit" href="#" contenteditable="false" id="bibcit_171" sno="5" apt_id="171">5</bibcit>]. FOXG1 Syndrome is a rare disorder with a prevalence of approximately 1 in every 40 000 live births. FOXG1 Syndrome is caused by mutations in the <i apt_id="172" id="i_172">FOXG1</i> gene found on chromosome 14 [<bibcit rid="504" title="bibcit" href="#" contenteditable="false" id="bibcit_173" sno="4" apt_id="173">4</bibcit>]. These mutations occur primarily <i apt_id="174" id="i_174">de novo</i> with a few cases being inherited by one of the unaffected parents and are typically loss-of-function classifying most FOXG1 Syndrome children as haploinsufficient disorders. <i apt_id="175" id="i_175">FOXG1</i> is a critical transcription factor whose overexpression and loss disrupt the excitatory/inhibitory balance during brain development [<bibcit rid="560" title="bibcit" href="#" contenteditable="false" id="bibcit_176" sno="7" apt_id="176">7</bibcit>, <bibcit rid="578" title="bibcit" href="#" contenteditable="false" id="bibcit_177" sno="8" apt_id="177">8</bibcit>]. Moreover, <i apt_id="178" id="i_178">FOXG1</i> overexpression has been described to affect the G2 phase of cell cycle [<bibcit rid="596" title="bibcit" href="#" contenteditable="false" id="bibcit_179" sno="9" apt_id="179">9</bibcit>], increase proliferation of neural stem cells [<bibcit rid="614" title="bibcit" href="#" contenteditable="false" id="bibcit_180" sno="10" apt_id="180">10</bibcit>], and stimulates dendrite elongation. Haploinsufficient mice and organoids modeling FoxG1 loss display altered neuronal connectivity and membrane excitability [<bibcit rid="560" title="bibcit" href="#" contenteditable="false" id="bibcit_181" sno="7" apt_id="181">7</bibcit>, <bibcit rid="578" title="bibcit" href="#" contenteditable="false" id="bibcit_182" sno="8" apt_id="182">8</bibcit>, <bibcit rid="632 650 667" title="bibcit" href="#" contenteditable="false" id="bibcit_183" sno="11 12 13" apt_id="183">11–13</bibcit>]. Together, <i apt_id="184" id="i_184">FOXG1</i> can be described as a dosage sensitive gene. Currently, there are no disease-modifying treatments for FOXG1 Syndrome marking a large unmet medical need.</p>
<p t="i" title="Paragraph Indented" apt_id="185" id="p_185">In the last decade, viral vectors, in particular adeno-associated virus (AAV), have emerged as a promising delivery modality for gene therapies. Currently, five AAV-based gene therapies are approved by the Federal Drug Administration, including Luxturna to treat an inherited form of blindness and Zolgensma for spinal muscular atrophy, with many more AAV-based gene therapies in clinical trials for neurological indications [<bibcit rid="685" title="bibcit" href="#" contenteditable="false" id="bibcit_186" sno="14" apt_id="186">14</bibcit>]. Out of the 660 HI genes, as many as 135 genes cannot be efficiently delivered via traditional recombinant (r)AAV-mediated gene replacement therapies, due to the limited 4.8 kilobase packaging limit of the viral vector [<bibcit rid="490" title="bibcit" href="#" contenteditable="false" id="bibcit_187" sno="3" apt_id="187">3</bibcit>]. Though FOXG1 meets the size limitation for gene replacement therapies, the creation of a modular, tunable gene regulation system may address concerns of dosage sensitivity, the need for multiple splice variants per gene, and as a platform to address the inclusion of the 525 HI genes that do not meet these criteria is needed. One potential way to bypass the hurdle of large gene delivery is by using a CRISPR activation strategy (CRISPRa) for therapeutic modulation of genes with abnormal dosage independent of gene size. In this approach, a gene is targeted using a nuclease-deficient dCas9 fused with proteins that upregulate target gene transcription when bound to a <i apt_id="188" id="i_188">cis</i>-regulatory element [<bibcit rid="703" title="bibcit" href="#" contenteditable="false" id="bibcit_189" sno="15" apt_id="189">15</bibcit>]. Here we developed a modular split CRISPRa system for dynamic regulation of the HI <i apt_id="190" id="i_190">FOXG1</i> gene and protein expression in cell lines and patient-derived cells in the absence of detectable off-target effects. Utilization of a split Streptococcus pyogenes dCas9 (SpdCas9) allows for the delivery of more than one fusion protein on the same dCas9 with limited AAV vectors and lack of potential competitive binding to the same locus. These proof-of-concept studies highlight the utility of programmable transcription in genetic medicine for haploinsufficient genes beyond <i apt_id="191" id="i_191">FOXG1</i> and the development of novel gene-size agnostic treatment modalities for neurodevelopmental disorders.</p>
</sect1><sect1 id="sect1_192" sec-type="materials|methods" apt_id="192"><ti title="Heading 1" apt_id="193" id="ti_193">Materials and methods</ti><sect2 id="sect2_194" apt_id="194"><ti title="Heading 2" apt_id="195" id="ti_195">Cloning of modular CRISPR constructs and sgRNAs</ti>
<p t="fl" title="Paragraph No Indent" apt_id="196" id="p_196">For the cloning of trans-spliced dCas9 constructs, G-blocks containing the respective intein and dCas9-terminal half sequences were ordered from IDT and subcloned into the pAAV backbone (Addgene Plasmid #115 790). For the cloning of <i apt_id="197" id="i_197">FOXG1</i> sgRNAs 20-bp spacer sequences were either selected from [<bibcit rid="721" title="bibcit" href="#" contenteditable="false" id="bibcit_198" sno="16" apt_id="198">16</bibcit>]<query><button type="button" title="Copy Editor to Author-AU: Please note that the reference citations in the  text have been reordered to be in sequential order. Check and correct where necessary directly in the references." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="15" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">15</span></button></query> or designed within ± 1kb of the <i apt_id="201" id="i_201">FOXG1</i> TSS using the online tool CHOPCHOP [<bibcit rid="739" title="bibcit" href="#" contenteditable="false" id="bibcit_202" sno="17" apt_id="202">17</bibcit>]. For transient transfection experiments, sgRNAs were cloned into a sgRNA expression vector (Addgene plasmid # 73 797) following a previously published protocol [<bibcit rid="757" title="bibcit" href="#" contenteditable="false" id="bibcit_203" sno="18" apt_id="203">18</bibcit>]. Spacer sequences used to create target-specific sgRNA expression vectors are listed in <url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="204" id="url_204">Supplementary Table S8</url>. All constructs were sequence confirmed by Sanger sequencing (Genewiz, Inc, South Plainfield, NJ, USA) and chromatograms were analyzed using SnapGene software (from GSL Biotech; available at snapgene.com).</p>
</sect2><sect2 id="sect2_205" apt_id="205"><ti title="Heading 2" apt_id="206" id="ti_206">Transient transfection experiments</ti>
<p t="fl" title="Paragraph No Indent" apt_id="207" id="p_207">Lenti-X 293T (Takara Bio USA, Inc., Mountain View, CA) were grown in media containing high-glucose DMEM supplemented with 1% L-glutamine (Thermo Fisher Scientific, Waltham, MA) and 10% HyClone heat-inactivated FBS (Thermo Fisher Scientific). For gene expression modulation experiments, cells per well were grown to 80% confluency and transfected within 24 hours of plating using Lipofectamine 3000 (Life Technologies) following the manufacturer's instructions with 3ul of Lipofectamine 3000 reagent diluted in 500ul Opti-MEM reduced serum media (Thermo Fisher Scientific). Transfections were performed in 12-well plates using either a mock-treatment (diluted transfection reagent) or 700 ng dCas9 expression vector and 300 ng of equimolar pooled sgRNA expression vectors. The transfection medium was replaced 24 hours post-transfection with complete growth medium. 48 hours post-transfection, cells were rinsed in 1X DPBS (Thermo) and lysed in the well using TriZol (Ambion, Austin, TX). Total RNA was extracted using the Direct-zol RNA Miniprep kit (Zymo Research, Irvine, CA) and 500 ng RNA was reverse transcribed using RevertAid First Strand cDNA Synthesis Kit according to the manufacturer's instructions using random hexamer primers. Real-time PCR was performed in triplicate with 20 ng of cDNA per reaction and PowerUp SYBR Green Master Mix (Thermo Fisher Scientific) using the StepOne Plus Real Time PCR system (Thermo Fisher Scientific) and the StepOne Plus software was used to extract raw CT values. Gene expression analysis was performed with <i apt_id="208" id="i_208">GAPDH</i> as a reference gene in three biological replicates using exon-spanning primers for <i apt_id="209" id="i_209">FOXG1</i>. Fold change of gene expression was calculated as the delta delta CT between <i apt_id="210" id="i_210">GAPDH</i> and target gene transcript levels normalized to respective control levels as the reference.</p>
</sect2><sect2 id="sect2_211" apt_id="211"><ti title="Heading 2" apt_id="212" id="ti_212">Western Blot</ti>
<p t="fl" title="Paragraph No Indent" apt_id="213" id="p_213">Protein lysates were quantified using the BCA assay (Pierce). Protein (10μg) was loaded onto SDS-PAGE gels (Bolt 4%–12% Bis-Tris Plus, Invitrogen) and separated using Tris-Gly buffer (Invitrogen). Proteins were transferred to the nitrocellulose membrane overnight at 4°C using the Wet/Tank Blotting Systems (Bio-Rad). Total protein was stained with Ponceau S stain before blocking the membrane in 20% Seablock in TBST (20 mmol/L Tris [pH 7.5], 150 mmol/L NaCl, 0.1% Tween) for one hour. Anti-FOXG1 antibody (1:1 000; ab68, abcam) and anti-β-actin antibody (1:4 000; A5441, MilliporeSigma) were used overnight at 4°C and subsequently incubated with 1:2000 rb680 and 1:2000 ms800 LICOR fluorescent secondary antibodies for 1.5 hours at room temperature. Western blot was incubated with the ECL Plus Reagent (Cytiva, MilliporeSigma), and the chemiluminescent signal was visualized using the Molecular Imager Gel Doc XR system (Bio-Rad). Intensities of FOXG1 protein bands were quantified using ImageJ and normalized to intensities of β-actin.</p>
</sect2><sect2 id="sect2_214" apt_id="214"><ti title="Heading 2" apt_id="215" id="ti_215">iPSC, NSC and neuronal cultures</ti>
<p t="fl" title="Paragraph No Indent" apt_id="216" id="p_216">Control iPSC (5315.101.1CC1) were purchased through Synthego (Redwood City). FOXG1 W308X and CRISPR-corrected iPSCs lines were kindly donated by Dr. Muotri laboratory (UC San Diego). The generation and characterization of these lines will be described in a manuscript in preparation. The iPSC lines were cultured in StemFlex (Gibco) on Matrigel (Corning), with media changed every 48h. To generate NSCs, EBs were formed on Aggrewell 800 (StemCell Technologies) for 24 hours before plating onto Ultra-Low Attachment dishes (Corning) in EB medium (Knockout DMEM/F12 (Gibco) and 15% KSR (Gibco) plus 100x NEAA, 100x Glutamax &amp; .55mM 2-Mercaptoethanol) for 3 days; media changed at 48h. EB media was supplemented with 500ng/mL Noggin (R&amp;D Systems) and 10uM SB431542 (Tocris) on day 2, 4 and 5 of starting differentiation. To promote rosette formation, EBs were plated onto GFR Matrigel (Corning) in EB media. After 24h, media was changed to NPC Medium (Neurobasal Medium (Gibco) plus Glutamax, NEAA, 1% Pen/Strep, 1% N2 &amp; 20ng/mL bFGF) for 5–6 days; media was changed every 48h. To obtain NSCs, rosettes were passaged as single cells on day 11–12 using Accutase (Sigma) and plated onto Poly-L-Ornithine/Laminin (Sigma) coated dishes in NSC media (NPC media plus .1% B27, 20ng/mL EGF, 10mg/mL Insulin &amp; 1.6% D-Glucose). NSCs were passaged once more before ICC analysis. NSCs were differentiated into neurons using NeuroCult™ NS-A Differentiation Kit (Human) (STEMCELL Technologies). NSCs were seeded at 2000 cells/cm2 on Poly-L-ornithine (Sigma-Aldrich) and Laminin (Sigma-Aldrich) coated 12-well plates and cultured for 88 days with half media changes every other day.</p>
</sect2><sect2 id="sect2_217" apt_id="217"><ti title="Heading 2" apt_id="218" id="ti_218">Immunocytochemistry</ti>
<p t="fl" title="Paragraph No Indent" apt_id="219" id="p_219">Neurons were rinsed in PBS and fixed in 4% paraformaldehyde (BioWorld) for 15 minutes. Neurons were washed in washing buffer (eBioscience™TBS Wash Buffer for IHC/ICC (Invitrogen) in molecular water), permeabilized in 0.1% triton (Sigma-Aldrich) in PBS and incubated in blocking solution (0.75g BSA + 35 ml PBS) for 1 hour. Primary antibody ms-beta III Tubulin (Abcam, ab78078) was incubated overnight at 4°C at 1:500. Secondary antibodies at 1:250; rb- Alexa Fluor™ 488 (Invitrogen, A-11008), ms- Alexa Fluor™ 594 (Invitrogen, A-11032), gp- Alexa Fluor™ 647 (Invitrogen, A-21450) were incubated at room temperature on a rocker for 1 hour. Neurons were washed in washing buffer and incubated in Hoechst (Tocris, 33 342) for 5 minutes. Neurons were washed a final time, and all imaging was performed with cells in washing buffer. Images were taken on the Zeiss Axio Observer.</p>
</sect2><sect2 id="sect2_220" apt_id="220"><ti title="Heading 2" apt_id="221" id="ti_221">RNA-seq</ti>
<p t="fl" title="Paragraph No Indent" apt_id="222" id="p_222">Global changes to transcription were assessed using RNA-Seq. Briefly, 300 000 cells for each treatment group were seeded in 6-well plates and allowed to grow to approximately 70% confluency. Cells were then rinsed in 1X DPBS and lysed in the well using TriZol (Ambion). Total RNA was extracted using the Direct-zol RNA Miniprep kit (Zymo Research). RNA was quantified with Nanodrop and 1ug of RNA was used for each library. RNA libraries were generated using the NEBNext Ultra II RNA Library Prep kit (NEB) following manufacturer's instructions. Libraries were multiplexed and pooled for a single lane of sequencing on a HiSeq4000. Sequencing reads were de-multiplexed and aligned to the Hg38 reference genome with STAR Universal Aligner version 2.5.3a using the following settings: Indexed Reference Genome: Ensembl reference genome and annotation files for Hg38 release 77 were downloaded and complied into a single file, Genome was indexed using the following arguments “STAR –runMode genomeGenerate –runThreadN 12 –genomeDir /STAR_INDEX_HG38 –genomeFastaFiles GRCh38_r77.all.fa –sjdbGTFfile Homo_sapiens.GRCh38.77.gtf –sjdbOverhang 149″; Sample Read Alignment: alignment of each sample's reads was performed with the following arguments: “STAR –runThreadN 24 –genomeDir /STAR_INDEX_HG38 –outFileNamePrefix /STAR/SampleName_ –outSAMtype BAM SortedByCoordinate –outWigType bedGraph –quantMode TranscriptomeSAM GeneCounts –readFilesCommand zcat –readFilesIn Sample-R1.fastq.gz Sample-R2.fastq.gz”. Differential Expression (DE) analysis was performed with edgeR software in R Studio. First, gene count files were combined into a single file. Then, normalization and DE analysis were performed relative to control. DE gene lists from pairwise comparisons were exported into .csv files and utilized for GO term analysis using stringdb (<url title="URL" type="uri" href="https://string-db.org/" apt_id="223" id="url_223">https://string-db.org/</url>). GO and volcano plots were generated using ggplot2 software in R studio.</p>
</sect2><sect2 id="sect2_224" apt_id="224"><ti title="Heading 2" apt_id="225" id="ti_225">Off-target analysis</ti>
<p t="fl" title="Paragraph No Indent" apt_id="226" id="p_226">Off-target analysis of CRISPR sgRNAs was performed using the CasOFFinder tool (<url title="URL" type="uri" href="http://www.rgenome.net/cas-offinder/" apt_id="227" id="url_227">http://www.rgenome.net/cas-offinder/</url>) (49). Briefly, 20bp spacer sequences for the three top sgRNA candidates without PAM sequences were used as the query using hg38 as the reference genome for canonical SpCas9 PAM sites. The algorithm was executed using 3 or less mismatches and DNA and RNA bulge sizes of 1. In order to extend the list from off-target sites to potential off-target genes, we included genes in a ± 5kb window using the Table Browser function of the UCSC Genome Browser. The list of off-target genes was then overlapped with all differentially expressed genes from the three conditions.</p>
</sect2><sect2 id="sect2_228" apt_id="228"><ti title="Heading 2" apt_id="229" id="ti_229">Statistical analysis</ti>
<p t="fl" title="Paragraph No Indent" apt_id="230" id="p_230">Statistical analyses were performed in Prism 8 (GraphPad Software, San Diego, CA) and in R Studio 3.6.0. Statistics are presented as the mean ± SD. Targeted assessments were performed in biological triplicates. Between-group differences were analyzed using a One-way analysis of variance (ANOVA). When appropriate, a Tukey's post hoc test was performed. Statistical differences between the means of two groups were determined using an independent samples t-Test. The <i apt_id="231" id="i_231">p</i>-value cut-off for all targeted analyses was set at 0.05 for all analyses.</p>
</sect2></sect1><sect1 id="sect1_232" sec-type="results" apt_id="232"><ti title="Heading 1" apt_id="233" id="ti_233">Results</ti><sect2 id="sect2_234" apt_id="234"><ti title="Heading 2" apt_id="235" id="ti_235"><i apt_id="236" id="i_236">In vitro</i> reconstitution of trans-spliced dCas9</ti>
<p t="fl" title="Paragraph No Indent" apt_id="237" id="p_237">To create a modular CRISPR system for gene regulation, the feasibility of an intein-mediated split SpdCas9 approach was assessed using intein sequences previously used for Cas9 [<bibcit rid="775 793 811" title="bibcit" href="#" contenteditable="false" id="bibcit_238" sno="19 20 21" apt_id="238">19–21</bibcit>]. Several split SpdCas9 modalities were designed (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="239" id="url_239">Supplementary Fig. S1</url>a) by fusing three bacteria-derived intein sequences to dCas9 (<i apt_id="240" id="i_240">Nostoc punctiforme (Npu) DNA Polymerase III DnaE</i> [<bibcit rid="775" title="bibcit" href="#" contenteditable="false" id="bibcit_241" sno="19" apt_id="241">19</bibcit>]<i apt_id="242" id="i_242">, Rhodothermus marinus (Rma) DNA helicase DnaB</i> [<bibcit rid="793" title="bibcit" href="#" contenteditable="false" id="bibcit_243" sno="20" apt_id="243">20</bibcit>] <i apt_id="244" id="i_244">and Mycobacterium xenopi (Mxe) Gyrase A</i> [<bibcit rid="811" title="bibcit" href="#" contenteditable="false" id="bibcit_245" sno="21" apt_id="245">21</bibcit>]. Expression of the intein-fusion protein was driven by a CMV promoter with a single SV40 NLS per split and a bGH polyA signal. The presence of a FLAG tag on the N-terminal split proteins and a C-terminal HA epitope allowed for the detection of the expression of the individual proteins as well as trans-spliced full-length dCas9. To demonstrate the reconstitution of dCas9, constructs were transfected individually or co-transfected into HEK293T cells. Transfection of the constructs resulted in the expression of all the individual N- and C-terminal intein-fusion proteins as demonstrated by Western Blot (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="246" id="url_246">Supplementary Fig. S1</url>b-c). Strikingly, the only detectable full-length dCas9 protein was mediated via <i apt_id="247" id="i_247">Rma</i>DnaB trans-splicing. This Rma intein protein architecture configuration was used for subsequent <i apt_id="248" id="i_248">in vitro</i> proof-of-principle experiments for modular CRISPR activation.</p>
</sect2><sect2 id="sect2_249" apt_id="249"><ti title="Heading 2" apt_id="250" id="ti_250">Transcriptional reprogramming of haploinsufficient FOXG1</ti>
<p t="fl" title="Paragraph No Indent" apt_id="251" id="p_251">To identify regions amenable to CRISPRa transcriptional reprogramming in the <i apt_id="252" id="i_252">FOXG1</i> gene we transiently co-transfected HEK293T cells with dCas9 constructs and gRNA expression vectors. We used intein-mediated split dCas9-VP64 (dC-V) or VP64-dCas9-VP64 (V-dC-V) expression plasmids. Plasmid expressing dCas9 without an effector domain was used as a control (dC). We designed five individual sgRNAs spanning DNase I hypersensitive sites and H3K4me3 peaks of the <i apt_id="253" id="i_253">FOXG1</i> promoter within a ± 1 kb window on either side of the transcriptional start site or used existing sgRNAs from a CRISPRa library [<bibcit rid="829" title="bibcit" href="#" contenteditable="false" id="bibcit_254" sno="22" apt_id="254">22</bibcit>] (Fig. <figcit rid="262" title="figcit" href="#" contenteditable="false" id="figcit_255" sno="1" apt_id="255">1</figcit>a). We performed RT-qPCR and observed significant activation of <i apt_id="256" id="i_256">FOXG1</i> expression with sgRNAs F1a (1.85-fold) and F8a (1.68-fold) when co-transfected with dC-V. In addition, we observed a significant increase in mRNA expression using V-dC-V for F1a (2.35-fold), F3a (1.99-fold) and F5a (1.95-fold) relative to dCas9-no effector control (dC). Based on previous findings that several sgRNAs are required for CRISPRa [<bibcit rid="847" title="bibcit" href="#" contenteditable="false" id="bibcit_257" sno="23" apt_id="257">23</bibcit>] we tested duplex sgRNA combinations paired with the most potent FOXG1 targeting sgRNA, F1a (Fig. <figcit rid="262" title="figcit" href="#" contenteditable="false" id="figcit_258" sno="1" apt_id="258">1</figcit>c). We did not observe a significant increase in <i apt_id="259" id="i_259">FOXG1</i> mRNA upregulation when duplexing sgRNAs relative to a single F1a sgRNA with either first-generation activator construct. Therefore, our results demonstrate the identification of a <i apt_id="260" id="i_260">cis</i>-regulatory element in the <i apt_id="261" id="i_261">FOXG1</i> promoter that allows for programmable transcription.</p>
<fig id="fig_262" prefix="Figure" suffix="." sno="1" type="arabic" sub-type="" apt_id="262"><ti title="Figure Caption" prefix="Figure" suffix="." sno="1" type="arabic" sub-type="" apt_id="263" id="ti_263"><b apt_id="264" id="b_264">(a) UCSC genome browser snapshot of the FOXG1 target sites</b>. <b apt_id="265" id="b_265">(b) <i apt_id="266" id="i_266">FOXG1</i> uniplex sgRNA screen.</b> We have identified individual lead sgRNAs for the targeted upregulation of <i apt_id="267" id="i_267">FOXG1</i> expression relative to their dCas9-no effector (dC) controls following a sgRNA screening in HEK293T cells using a single N-terminal (V-dC) or dual VP64 (V-dC-V) via RT-qPCR. 2way ANOVA with Tukey's multiple comparison test, * significant (<i apt_id="268" id="i_268">p</i> &lt; 0.05), n = 3 <b apt_id="269" id="b_269">(c) Duplex screen of FOXG1 sgRNAs.</b> 2way ANOVA with Tukey's multiple comparison test, * significant (<i apt_id="270" id="i_270">p</i> &lt; 0.05), n = 3<query><button type="button" title="Copy Editor to Author-AU: Figures have been edited to conform to journal style. Please check all figures carefully. If any adjustments are needed, where possible please note these as instructions to the typesetter rather than providing a replacement figure." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="16" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">16</span></button></query>.</ti><img src="https://pxeqa.aptaracorp.com/pxestore/assets/pxeoup6qa/NARMME/ugaf011//images/ugaf011_f1.jpg" title="Figure" width="600" height="auto" apt_id="273" id="img_273" /><button class="btn_inline_img noneditable btn btn-info btn-sm" onclick="AptEditorImgManager.initImageManagerButton($(e.target).prev()[0]);" apt_id="274" id="button_274"><i class="fa-solid fa-pen-to-square" apt_id="275" id="i_275"></i></button></fig></sect2><sect2 id="sect2_276" apt_id="276"><ti title="Heading 2" apt_id="277" id="ti_277">CRISPR activators allow for wide dynamic range of haploinsufficient gene expression</ti>
<p t="fl" title="Paragraph No Indent" apt_id="278" id="p_278">Hereafter, we sought to investigate whether stronger activator fusions could increase the amount of <i apt_id="279" id="i_279">FOXG1</i> mRNA produced. Split constructs encoding V-dC, V-dC-V, synergistic activation modulator (SAM, dC-MPH) [<bibcit rid="865" title="bibcit" href="#" contenteditable="false" id="bibcit_280" sno="24" apt_id="280">24</bibcit>], dCas9-p300 (dC-P) [<bibcit rid="829" title="bibcit" href="#" contenteditable="false" id="bibcit_281" sno="22" apt_id="281">22</bibcit>], and a mini VP64-p65-Rta (VPR-dC) [<bibcit rid="883" title="bibcit" href="#" contenteditable="false" id="bibcit_282" sno="25" apt_id="282">25</bibcit>] tripartite activator construct were co-transfected in HEK293T cells using the lead <i apt_id="283" id="i_283">FOXG1</i> sgRNA F1a. All experiments were normalized to a dCas9 no effector co-transfected with the respective sgRNA. We identified a significant increase in <i apt_id="284" id="i_284">FOXG1</i> mRNA when using V-dC-V (2.53-fold), VPR-dC (2.78-fold) or dC-MPH (2.85-fold) relative to dC-V and dC (Fig. <figcit rid="289" title="figcit" href="#" contenteditable="false" id="figcit_285" sno="2" apt_id="285">2</figcit>a). We did not observe any significant differences between using V-dC-V, MPH or VPR. No significant mRNA upregulation was observed using dC-P (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="286" id="url_286">Supplementary Fig. S2</url>). Co-transfection of VPR-dC-MPH paired with two and up to three sgRNAs (F1a + 4a, F1a + 4a + 6a) demonstrated significant upregulation relative to any other split dCas9 activator fusion sgRNA pairing (Fig. <figcit rid="289" title="figcit" href="#" contenteditable="false" id="figcit_287" sno="2" apt_id="287">2</figcit>b). All four sgRNAs that were able to demonstrate gene regulation individually did not yield a synergistic activation effect on <i apt_id="288" id="i_288">FOXG1</i> expression (F1a + 4a + 5a + 6a).</p>
<fig id="fig_289" prefix="Figure" suffix="." sno="2" type="arabic" sub-type="" apt_id="289"><ti title="Figure Caption" prefix="Figure" suffix="." sno="2" type="arabic" sub-type="" apt_id="290" id="ti_290"><b apt_id="291" id="b_291">(a) CRISPR activator comparison for FOXG1 regulation</b>. We evaluated our selected lead sgRNA with all our CRISPRa constructs and found a dynamic range in the amount of <i apt_id="292" id="i_292">FOXG1</i> expression we can induce in HEK293Ts where, similar to the dual VP64 fusion (V-dC-V), the N-terminal dCas9 miniature VPR (VP64-p65-Rta, VPR-dC) and dCas9 C-terminal P2A-MPH (MS2core-p65-HSF1, dC-MPH) constructs can induce <i apt_id="293" id="i_293">FOXG1</i> overexpression, measured via RT-qPCR. Ordinary one-way ANOVA with Tukey's multiple comparison test * significant (<i apt_id="294" id="i_294">p</i> &lt; 0.05), n = 3. <b apt_id="295" id="b_295">(b) Multiplexing sgRNAs with strong CRISPR activators.</b> Lead sgRNA 1 was further multiplexed with other sgRNAs in combination with VPR and MPH (VPR-dC-MPH). F1a + 4a and F1a + 4a + 6a result in the greatest amount of <i apt_id="296" id="i_296">FOXG1</i> overexpression, via RT-qPCR. F1a was selected for further evaluation. Ordinary one-way ANOVA with Tukey's multiple comparison test * significant (<i apt_id="297" id="i_297">p</i> &lt; 0.05), n = 3.</ti><img src="https://pxeqa.aptaracorp.com/pxestore/assets/pxeoup6qa/NARMME/ugaf011//images/ugaf011_f2.jpg" title="Figure" width="600" height="auto" apt_id="298" id="img_298" /><button class="btn_inline_img noneditable btn btn-info btn-sm" onclick="AptEditorImgManager.initImageManagerButton($(e.target).prev()[0]);" apt_id="299" id="button_299"><i class="fa-solid fa-pen-to-square" apt_id="300" id="i_300"></i></button></fig>
<p t="i" title="Paragraph Indented" apt_id="301" id="p_301">Finally, we also determined if <i apt_id="302" id="i_302">FOXG1</i> mRNA expression results in a significant increase in FoxG1 protein relative to mock-treated HEK293T cells (Fig. <figcit rid="305" title="figcit" href="#" contenteditable="false" id="figcit_303" sno="3" apt_id="303">3</figcit>a). Significant protein increase was observed in cells treated with V-dC-V (1.27-fold), VPR-dC (1.25-fold), as well as VPR-dC-MPH with F1a4a (1.36-fold) or only F1a (1.5-fold) relative to dC. No significant differences were observed between V-dC-V, VPR-dC and VPR-dC-MPH (Fig. <figcit rid="305" title="figcit" href="#" contenteditable="false" id="figcit_304" sno="3" apt_id="304">3</figcit>b). Based on these data we decided to utilize a combination of VPR and SAM for subsequent experiments.</p>
<fig id="fig_305" prefix="Figure" suffix="." sno="3" type="arabic" sub-type="" apt_id="305"><ti title="Figure Caption" prefix="Figure" suffix="." sno="3" type="arabic" sub-type="" apt_id="306" id="ti_306"><b apt_id="307" id="b_307">(a) FOXG1 protein modulation in HEK293T.</b> Representative Western blot of protein from HEK293T cells that were transfected with lead CRISPRa combinations to upregulate <i apt_id="308" id="i_308">FOXG1</i> expression. FoxG1 shown at approximately 50kDa, Actin shown at approximately 42kDa. <b apt_id="309" id="b_309">(b)</b> Lead sgRNA combinations demonstrate significant upregulation of FoxG1 protein expression as compared to dC control. The additional inclusion of sgRNA 4 does not potentiate total FOXG1 protein upregulation as previously seen in transcriptional data. There is an observable ceiling effect of approximately 2-fold FOXG1 protein expression as compared to dC controls. Ordinary one-way ANOVA with Dunnett's multiple comparison test * significant relative to dC (<i apt_id="310" id="i_310">p</i> &lt; 0.05), n = 3.</ti><img src="https://pxeqa.aptaracorp.com/pxestore/assets/pxeoup6qa/NARMME/ugaf011//images/ugaf011_f3.jpg" title="Figure" width="600" height="auto" apt_id="311" id="img_311" /><button class="btn_inline_img noneditable btn btn-info btn-sm" onclick="AptEditorImgManager.initImageManagerButton($(e.target).prev()[0]);" apt_id="312" id="button_312"><i class="fa-solid fa-pen-to-square" apt_id="313" id="i_313"></i></button></fig></sect2><sect2 id="sect2_314" apt_id="314"><ti title="Heading 2" apt_id="315" id="ti_315">Modular CRISPRa approach is highly specific for FOXG1 target site in wildtype NSC</ti>
<p t="fl" title="Paragraph No Indent" apt_id="316" id="p_316">To evaluate the effect of targeting <i apt_id="317" id="i_317">FOXG1</i> with VPR-dC-MPH on global gene expression we performed RNA-seq in neural stem cells (NSCs) derived from a healthy control (Fig. <figcit rid="336" title="figcit" href="#" contenteditable="false" id="figcit_318" sno="4" apt_id="318">4</figcit>a). NSCs were co-transfected with CRISPRa constucts and sgRNA combination F1a + F4a. We observed that neural stem cells had a similar amenability to modular, programmable transcription as was observed in HEK293T cells in which a combination of VPR and MPH was able to induce a 3.48-fold upregulation in <i apt_id="319" id="i_319">FOXG1</i> expression (Fig. <figcit rid="336" title="figcit" href="#" contenteditable="false" id="figcit_320" sno="4" apt_id="320">4</figcit>b). Significant upregulation of <i apt_id="321" id="i_321">FOXG1</i> was detected by RNA-seq in the 5315.101.1CC1 control cells treated with VPR-dC-MPH when compared dC (3.53-fold) (Fig. <figcit rid="336" title="figcit" href="#" contenteditable="false" id="figcit_322" sno="4" apt_id="322">4</figcit>c). In total, we identified 94 significantly upregulated genes in VPR-dC-MPH and only two significantly downregulated genes (log<sub apt_id="323" id="sub_323">2</sub>FC &gt; 1.5 &lt; -1.5, <url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="324" id="url_324">Supplementary Table S1</url>). Although <i apt_id="325" id="i_325">FOXG1</i> sgRNA sequences were designed to target a unique site in the human genome, it is possible that the sgRNAs can tolerate mismatches leading to off-target binding. In order to address this issue, we searched for potential off-target (OT) sites with up to 3 mismatches within the sgRNA sequences using CasOFF-Finder, which scans for both nucleotide mismatches and bulges in the sequence, thereby making it a comprehensive <i apt_id="326" id="i_326">in silico</i> prediction tool for OT analysis [<bibcit rid="901" title="bibcit" href="#" contenteditable="false" id="bibcit_327" sno="26" apt_id="327">26</bibcit>]. To include OT sites that fall within intergenic regions, we extended the targets by ± 5kb from the predicted OT site to include neighboring transcripts and identified a total of 19 predicted OT genes (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="328" id="url_328">Supplementary Table S2</url>). Strikingly, the majority of OT sites required at least 3 mismatches in F1a. Out of 18 OT genes, we identified no putative off-target loci differentially expressed in CRISPRa treated cells (Fig. <figcit rid="336" title="figcit" href="#" contenteditable="false" id="figcit_329" sno="4" apt_id="329">4</figcit>d). A gene ontology analysis revealed significant enrichment of 125 GO-terms largely related to viral defense responses (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="330" id="url_330">Supplementary Table S3</url>). The only direct identified target to interact with <i apt_id="331" id="i_331">FOXG1</i> found to be significantly upregulated was the transcription factor <i apt_id="332" id="i_332">EMX1</i> (4.52 log<sub apt_id="333" id="sub_333">2</sub>-fold, <i apt_id="334" id="i_334">p</i> &lt; 0.05). We demonstrate that the modular split CRISPRa system is highly specific for the intended target site. Following a 40-day NeuroCult differentiation of healthy NSCs into mixed neuronal cultures, we identified that FOXG1 expression was significantly upregulated in cells treated with VPR-dC-MPH relative to dC (Fig. <figcit rid="336" title="figcit" href="#" contenteditable="false" id="figcit_335" sno="4" apt_id="335">4</figcit>e-f). This demonstrates the ability to modulate gene expression in a cell type that relates to the affected tissue within FOXG1 Syndrome.</p>
<fig id="fig_336" prefix="Figure" suffix="." sno="4" type="arabic" sub-type="" apt_id="336"><ti title="Figure Caption" prefix="Figure" suffix="." sno="4" type="arabic" sub-type="" apt_id="337" id="ti_337"><b apt_id="338" id="b_338">(a) Graphical representation of NSC to neuron differentiation protocol.</b> (<b apt_id="339" id="b_339">b</b>) <b apt_id="340" id="b_340">FOXG1 modulation in control neural stem cells.</b> SgRNA F1a + F4a were evaluated with panel of CRISPRa constructs in wild-type neural stem cells and recapitulate a similar 3–4 fold increase in FOXG1 expression as seen in HEK293Ts. Ordinary one-way ANOVA with Tukey's multiple comparison test, * significant to VPR-dC-MPH (<i apt_id="341" id="i_341">p</i> &lt; 0.05), n = 3. <b apt_id="342" id="b_342">(c) <i apt_id="343" id="i_343">FOXG1</i> expression change from RNA sequencing data.</b> Unpaired t-test, * indicates significance (<i apt_id="344" id="i_344">p</i> &lt; 0.05), n = 2. <b apt_id="345" id="b_345">(d) Overlap of differentially expressed genes following FOXG1 CRISPRa targeting and <i apt_id="346" id="i_346">in silico</i> predicted off-target effects. (e) Representative image of iPSC-derived neurons at Day 40 of NeuroCult differentiation protocol.</b> These cells demonstrate neuronal cell morphology and positivity of the mature neuronal marker Tuj1 (10x). <b apt_id="347" id="b_347">(f) <i apt_id="348" id="i_348">FOXG1</i> modulation in neurons.</b> Day 40 iPSC-derived neurons were transfected with VPR-dC-MPH with F1a and demonstrate a similar 4-fold upregulation of <i apt_id="349" id="i_349">FOXG1</i> gene expression as previously seen in HEK293T and NSC data. Unpaired t-test, * indicates significance (<i apt_id="350" id="i_350">p</i> &lt; 0.05), n = 4.</ti><img src="https://pxeqa.aptaracorp.com/pxestore/assets/pxeoup6qa/NARMME/ugaf011//images/ugaf011_f4.jpg" title="Figure" width="600" height="auto" apt_id="351" id="img_351" /><button class="btn_inline_img noneditable btn btn-info btn-sm" onclick="AptEditorImgManager.initImageManagerButton($(e.target).prev()[0]);" apt_id="352" id="button_352"><i class="fa-solid fa-pen-to-square" apt_id="353" id="i_353"></i></button></fig></sect2><sect2 id="sect2_354" apt_id="354"><ti title="Heading 2" apt_id="355" id="ti_355">Mutant <i apt_id="356" id="i_356">FOXG1</i> neuronal cells reveal pathways enriched in neurological function</ti>
<p t="fl" title="Paragraph No Indent" apt_id="357" id="p_357">We then performed transcriptomic analysis on patient-iPSC derived NSC and CRISPR-edited isogenic control cells (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="358" id="url_358">Supplementary Table S4</url>). FOXG1 mutant iPSC carry a W308X mutation that has previously been identified to result in loss of function of <i apt_id="359" id="i_359">FOXG1</i> (<url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="360" id="url_360">Supplementary Fig. S3</url>) [<bibcit rid="918" title="bibcit" href="#" contenteditable="false" id="bibcit_361" sno="27" apt_id="361">27</bibcit>]. Surprisingly, <i apt_id="362" id="i_362">FOXG1</i> expression in mutant cells was 0.89-fold reduced (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_363" sno="5" apt_id="363">5</figcit>a). In total, we identified 800 differentially expressed genes (DEGs) in mutant cells relative to isogenic controls (623 upregulated and 177 downregulated genes log<sub apt_id="364" id="sub_364">2</sub>FC &gt; 1.5 &lt; -1.5, Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_365" sno="5" apt_id="365">5</figcit>c). The most significantly downregulated gene was <i apt_id="366" id="i_366">SIX2</i> (-4.42 log<sub apt_id="367" id="sub_367">2</sub>FC) and the most upregulated gene was <i apt_id="368" id="i_368">CHCHD2</i> (11.16 log<sub apt_id="369" id="sub_369">2</sub>FC). We observed that VPR-dC-MPH F1a increased mRNA 3.55-fold relative to dC in W308X cells (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_370" sno="5" apt_id="370">5</figcit>b, <url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="371" id="url_371">Supplementary Table S5</url>). While the upregulation approach was similar in magnitude to HEK293T and neural stem cells in previous experiments, the increase in <i apt_id="372" id="i_372">FOXG1</i> mRNA resulted only in approximately 39% of expression rescued relative to the CRISPR-corrected cell line. In mutant CRISPRa treated cells we observed a total of 102 DEGs relative to dC and did not find any overlap with predicted off-target sites. The only transcriptional change observed in W308X neural stem cells treated with VPR-dC-MPH relative to dC was of <i apt_id="373" id="i_373">FOXG1</i> (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_374" sno="5" apt_id="374">5</figcit>c). Gene ontology analysis for upregulated genes in biological pathways revealed enrichment of genes involved in regulation of postsynaptic density assembly, regulation of neuron migration and dendrite morphogenesis (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_375" sno="5" apt_id="375">5</figcit>d, <url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="376" id="url_376">Supplementary Table S6</url>). Downregulated genes were significantly enriched for biological processes related to cerebral cortex GABAergic interneuron fate commitment, amongst others. In CRISPR-corrected cells that were treated with VPR-dC-MPH F1a, we observed significant upregulation of 57 genes and significant downregulation of two genes relative to cells that were targeted with dC + F1a (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_377" sno="5" apt_id="377">5</figcit>d, <url title="URL" type="uri" href="https://academic.oup.com/narmme/article-lookup/doi/10.1093/narmme/ugaf011#supplementary-data" apt_id="378" id="url_378">Supplementary Table S7</url>). We identified FGF/EGF as key central genes involved in neural stem cell proliferation. Downregulated genes were enriched for regionalization and anterior/posterior pattern specification. For genes that were significantly downregulated, we identified several transcription factors that are known FoxG1 interaction partners including <i apt_id="379" id="i_379">DLX1</i>, <i apt_id="380" id="i_380">DLX2</i>, <i apt_id="381" id="i_381">EBF1</i>, <i apt_id="382" id="i_382">EMX2</i>, <i apt_id="383" id="i_383">LHX2</i>, <i apt_id="384" id="i_384">MEIS2</i>, <i apt_id="385" id="i_385">NR2F1</i> and <i apt_id="386" id="i_386">VAX1</i> involved in neural cell fate specification and differentiation, and forebrain development. Significantly upregulated genes were enriched in Glutamate receptor activity and Molecular Function GO-terms for Glutamate receptor activity Voltage-gated potassium channel activity (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_387" sno="5" apt_id="387">5</figcit>e). We differentiated two additional lines carrying known FOXG1 loss of function mutations, c.256dupC and 670G &gt; A, and treated these with our modular activators (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_388" sno="5" apt_id="388">5</figcit>f). We utilized a control NSC line, 80230f, as a reference point for <i apt_id="389" id="i_389">FOXG1</i> mRNA expression. We identified that both lines had significantly reduced <i apt_id="390" id="i_390">FOXG1</i> levels, demonstrating a 0.92-fold and 0.77-fold change for 256dupC and 670G &gt; A. Treatment with the modular CRISPRa system resulted in a 2.34-fold and 1.51-fold increase relative to cells treated with dC only. Finally, neural stem cells were differentiated into cortical neurons (Fig. <figcit rid="393" title="figcit" href="#" contenteditable="false" id="figcit_391" sno="5" apt_id="391">5</figcit>g-h) and transfected with VPR-dC-MPH F1a. As observed in the W308X neural stem cells there was a significant 90% decrease in <i apt_id="392" id="i_392">FOXG1</i> expression between mutant and isogenic neurons. The modular CRISPRa resulted in restoration of up to 54% FOXG1 expression relative to the isogenic control, highlighting the potential of this approach for gene regulation in postmitotic cells.</p>
<fig id="fig_393" prefix="Figure" suffix="." sno="5" type="arabic" sub-type="" apt_id="393"><ti title="Figure Caption" prefix="Figure" suffix="." sno="5" type="arabic" sub-type="" apt_id="394" id="ti_394"><b apt_id="395" id="b_395">(A) FOXG1 levels in W308X mutant neural stem cells.</b> FOXG1 syndrome W308X neural stem cells have approximately 10% expression of FOXG1 relative to CRISPR corrected controls (iso). Targeted upregulation with sgRNA 1 and CRISPRa (VPR-dC-MPH) results in a 4-fold increase in mRNA. Ordinary one-way ANOVA with Tukey's multiple comparison test * significant (<i apt_id="396" id="i_396">p</i> &lt; 0.05), n = 3. <b apt_id="397" id="b_397">(B) Smear plot demonstrating significant FOXG1 upregulation in W308X following CRISPRa treatment.</b> VPR-dC-MPH + F1a relative to dCas9 (dC). <b apt_id="398" id="b_398">(C) Transcriptome profiling of mutant cells.</b> Volcano plots demonstrating changes in FOXG1 expression before and after transfection of VPR-dC-MPH relative to isogenic cells. Left: Mutant cells to isogenic control cells each treated with dCas9 (dC). Right: Mutant cells treated with CRISPRa (VPR-dC-MPH) relative to isogenic control cells treated with dCas9 (dC). <b apt_id="399" id="b_399">(D) Gene Ontology Analysis in mutant versus wildtype cells</b>. GO analysis shows enrichment for biological processes in significantly up- or downregulated genes. <b apt_id="400" id="b_400">(E) String analysis for differentially expressed genes in FOXG1 mutant cells.</b> StringDB maps showing interaction networks of differentially expressed genes in FOXG1 mutant cells for two terms, Glutamate Receptor activity and voltage-gated potassium channel activity. <b apt_id="401" id="b_401">(F) Representative image of iPSC-derived neurons at Day 40 of NeuroCult differentiation protocol</b>. These cells demonstrate neuronal cell morphology and positivity of the mature neuronal marker TUJ1 (10x). <b apt_id="402" id="b_402">(G) FOXG1 modulation in mutant neurons.</b> Day 40 iPSC-derived neurons were transfected with lead CRISPRa construct miniVPR + MPH with sgRNA 01 and demonstrate upregulation of <i apt_id="403" id="i_403">FOXG1</i> gene expression. Ordinary one-way ANOVA with Tukey's multiple comparison test * significant (<i apt_id="404" id="i_404">p</i> &lt; 0.05), n = 3.</ti><img src="https://pxeqa.aptaracorp.com/pxestore/assets/pxeoup6qa/NARMME/ugaf011//images/ugaf011_f5.jpg" title="Figure" width="600" height="auto" apt_id="405" id="img_405" /><button class="btn_inline_img noneditable btn btn-info btn-sm" onclick="AptEditorImgManager.initImageManagerButton($(e.target).prev()[0]);" apt_id="406" id="button_406"><i class="fa-solid fa-pen-to-square" apt_id="407" id="i_407"></i></button></fig></sect2></sect1><sect1 id="sect1_408" sec-type="discussion" apt_id="408"><ti title="Heading 1" apt_id="409" id="ti_409">Discussion</ti>
<p t="fl" title="Paragraph No Indent" apt_id="410" id="p_410">Many neurological disorders result from insufficient dosage of proteins. These dosage sensitive HI genes are frequently master regulators involved in developmental processes [<bibcit rid="479" title="bibcit" href="#" contenteditable="false" id="bibcit_411" sno="2" apt_id="411">2</bibcit>]. <i apt_id="412" id="i_412">FOXG1</i> is a transcription factor that is expressed in early development and plays a critical role in the establishment of the regional subdivision of the developing brain and in the development of the telencephalon. Mutations in <i apt_id="413" id="i_413">FOXG1</i> result in a rare neurological disorder that is characterized by intellectual disability and seizures. One potential route to mitigate neurological deficits observed due to <i apt_id="414" id="i_414">FOXG1</i> haploinsufficiency is the upregulation of the functional copy of the gene in individuals with heterozygous loss-of-function mutations. Here, we have developed a modular system that is based on an intein-mediated split protein that post-translationally recombines in target cells. Though smaller orthologs of Cas9 are currently being evaluated, SpdCas9 remains canonical in the field as its targeting efficiency and specificity are well understood, therefore an intein-based system to allow for SpdCas9 packaging is preferred. Future studies will address delivery of targeting modalities in animal models of <i apt_id="415" id="i_415">FOXG1</i> and other HI genes. The modular CRISPRa system developed here allows for dynamic gene regulation of target genes by allowing easy reconfiguration between different amino- and carboxyterminal fused activator domains. The necessity of recombination between amino- and carboxyterminal domains ensures uniform and synergistic activation at the desired locus that is not guaranteed with the use of two separate dCas9 plasmids. Here we demonstrate upregulation of <i apt_id="416" id="i_416">FOXG1</i> expression in human cell lines and patient-derived cells that also results in significant increase in FoxG1 protein levels. As this CRISPRa mediated increase in total <i apt_id="417" id="i_417">FOXG1</i> expression is not allele specific, due to the nature of the heterozygous loss-of-function mutations, we do not find it necessary for such a level of specificity. Similar to previously published results [<bibcit rid="936" title="bibcit" href="#" contenteditable="false" id="bibcit_418" sno="28" apt_id="418">28</bibcit>], we find that next-generation activator domains, including MS2-loop mediated recruitment of p65 and HSF1 via the guide RNA, as well as a miniature VP64, p65 and Rta transactivator tripartite domain can significantly increase <i apt_id="419" id="i_419">FOXG1</i> mRNA levels relative to a first-generation single VP64 fusion protein. Strikingly various increases in <i apt_id="420" id="i_420">FOXG1</i> expression levels did not yield significant protein level increases highlighting a non-linear relationship between transcription and translation of the <i apt_id="421" id="i_421">FOXG1</i> gene. We also identify that the <i apt_id="422" id="i_422">FOXG1</i> gene can be further modulated by multiplexing sgRNAs targeting the gene promoter. Targeting different genes might require different activation strategies for expanding this technology to other haploinsufficient loss-of-function mutations. We also identify that this approach can significantly upregulate gene expression in neuronal models following differentiation protocols of iPSCs from healthy and disease individuals. We find that our approach is highly specific for the intended target site, but future studies will need to correlate gene expression changes to binding of dCas9 protein, since prediction tools overpredict off-target sites and may miss empirically found off-targets. In cells that were derived from apparently healthy controls we find that significant upregulation of <i apt_id="423" id="i_423">FOXG1</i> results in upregulation of genes involved in immune function. Previous studies suggest a role for <i apt_id="424" id="i_424">FOXG1</i> overexpression in immune responses [<bibcit rid="954" title="bibcit" href="#" contenteditable="false" id="bibcit_425" sno="29" apt_id="425">29</bibcit>]. Within CRISPRa approaches, potential effects of target overexpression should be considered, though our methods, within mutant lines, do not exceed 100% of WT <i apt_id="426" id="i_426">FOXG1.</i> Critically, when utilizing mutant W308X neural lines, we find that mutant cells do not demonstrate haploinsufficiency in which 50% of expression of a gene is observed, but rather 10%. While our approach is still able to significantly upregulate gene expression in a magnitude observed in HEK293T and control neural stem cells, this gene upregulation results in only 39% expression levels of what a CRISPR-corrected control cell line is. Similar findings were observed following cortical induction protocols, in which the modular CRISPRa system resulted in activation of up to 54% gene expression relative to healthy controls. This highlights that disease-models of FOXG1 have additional mechanisms that require studying. Mutant cells had differentially expressed genes that were enriched for biological pathways related to postsynaptic density assembly, regulation of neuron migration and dendrite morphogenesis and GABAergic cells. In addition, genes were significantly enriched for terms involved in molecular function including ionotropic glutamate receptor activity and voltage-gated ion channel activity. These findings highlight the critical role of <i apt_id="427" id="i_427">FOXG1</i> in the development, specification and function of neuronal cells in accordance with literature [<bibcit rid="560" title="bibcit" href="#" contenteditable="false" id="bibcit_428" sno="7" apt_id="428">7</bibcit>, <bibcit rid="578" title="bibcit" href="#" contenteditable="false" id="bibcit_429" sno="8" apt_id="429">8</bibcit>, <bibcit rid="632 650 667" title="bibcit" href="#" contenteditable="false" id="bibcit_430" sno="11 12 13" apt_id="430">11–13</bibcit>]. This critical role may lend insight to the need for early therapeutic intervention for <i apt_id="431" id="i_431">FOXG1</i> haploinsufficiency, though the exact timing is not yet deduced. Moreover, the ability to increase <i apt_id="432" id="i_432">FOXG1</i> mRNA in post-mitotic cells suggests an amenable delivery window, though phenotypic rescue experiments would be needed for a full evaluation. Understanding gene signatures associated with disease will help further elucidate future rescue experiments using additional FOXG1 mutant cell models. In the current study, we only find <i apt_id="433" id="i_433">FOXG1</i> gene expression altered following genetic intervention. The lack of additional changes in gene expression of <i apt_id="434" id="i_434">FOXG1</i> downstream targets may be due to the transient nature of experiments conducted in this study, where effects were assessed 48 hours post-transfection. Future studies will need to address the long-term, stable expression of the modular CRISPRa system proposed here. In addition, future experiments will study cellular morphology, such as soma size and neurite length and the impact a gene modification strategy has on cellular phenotypes. This approach has the potential to serve as a platform technology to be expanded to other HI genes and beyond.</p>
</sect1><sect1 id="sect1_435" sec-type="author-contribution" apt_id="435"><ti title="Heading 1" apt_id="436" id="ti_436">Author contribution</ti>
<p t="fl" title="Paragraph No Indent" apt_id="437" id="p_437">JANMH participated in conceptualization, data curation, formal analysis, methodology, visualization, writing the original draft and reviewing and editing, CEG, JLC, JJW, DLC, AAQ, and LTT participated in data curation, formal analysis, and methodology, ARM and KDF participated in conceptualization, formal analysis, funding acquisition, project administration, resources, supervision, review, editing, and final approval of the manuscript.</p>
</sect1><sect1 id="sect1_438" sec-type="supplementary-data" apt_id="438"><ti title="Heading 1" apt_id="439" id="ti_439">Supplementary data</ti>
<p t="fl" title="Paragraph No Indent" apt_id="440" id="p_440">Supplementary data is available at NAR Molecular Medicine online.</p>
</sect1><sect1 id="sect1_441" sec-type="ConflictofInterest" apt_id="441"><ti title="Heading 1" apt_id="442" id="ti_442">Conflict of interest</ti>
<p t="fl" title="Paragraph No Indent" apt_id="443" id="p_443">None declared.</p>
</sect1><sect1 id="sect1_444" sec-type="data-availability" apt_id="444"><ti title="Heading 1" apt_id="445" id="ti_445">Data availability</ti>
<p t="fl" title="Paragraph No Indent" apt_id="446" id="p_446">The data underlying this article are available in Gene Expression Omnibus at <query><button type="button" title="Copy Editor to Author-AU: Please note that the URL 'https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE275547' is not valid/accessible. Please check and include a working URL directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="17" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">17</span></button></query><url title="URL" type="uri" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE275547" apt_id="449" id="url_449">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE275547</url> and can be accessed with GSE275547. The data underlying this article are available in the article and in its online supplementary material<query><button type="button" title="Copy Editor to Author-AU: Please ensure all 'conflicts of interest' (or 'disclosures') have been included for you and your co-authors, and that this section is correct. Edit the text directly if changes are required." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="18" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">18</span></button></query><query><button type="button" title="Copy Editor to Author-AU: Supplementary Data having 'False' value in metadata but supplementary section found in pre-edit file. Please check." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="19" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">19</span></button></query><query><button type="button" title="Copy Editor to Author-AU: Please check that funding is recorded in a separate funding section, if applicable. Use the full official names of any funding bodies and include any grant numbers. Insert any changes to the funding section directly in the text." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="20" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">20</span></button></query><query><button type="button" title="Copy Editor to Author-AU: Details given in references:bib4,bib7 were the same. Hence, these references have been deleted and the renumbered accordingly." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="21" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">21</span></button></query>.</p>
</sect1></bdy><bm apt_id="458" id="bm_458"><ref type="arabic" sno="1" suffix="." id="ref_459" apt_id="459"><ti title="Bibliography Heading" apt_id="460" id="ti_460">References</ti><bib type="arabic" id="bib_461" sno="1" suffix="." apt_id="461"><jcit apt_id="462" id="jcit_462"><au apt_id="463" id="au_463"><s title="Surname" apt_id="464" id="s_464">Sarel-Gallily</s><f title="First name" apt_id="465" id="f_465">R</f></au>, <au apt_id="466" id="au_466"><s title="Surname" apt_id="467" id="s_467">Golan-Lev</s><f title="First name" apt_id="468" id="f_468">T</f></au>, <au apt_id="469" id="au_469"><s title="Surname" apt_id="470" id="s_470">Yilmaz</s><f title="First name" apt_id="471" id="f_471">A</f></au>, <etal title="etal" apt_id="472" id="etal_472">et al.</etal> <at title="Article Title" apt_id="473" id="at_473">Genome-wide analysis of haploinsufficiency in Human embryonic stem cells</at>. <pt title="Periodical Title" apt_id="474" id="pt_474">Cell Rep</pt> <yr title="Year" apt_id="475" id="yr_475">2022</yr>;<v title="Volume" apt_id="476" id="v_476">38</v>:<pages title="Pages" apt_id="477" id="pages_477">110573</pages>. <url title="URL" type="uri" href="https://doi.org/10.1016/j.celrep.2022.110573" apt_id="478" id="url_478">https://doi.org/10.1016/j.celrep.2022.110573</url> </jcit></bib><bib type="arabic" id="bib_479" sno="2" suffix="." apt_id="479"><jcit apt_id="480" id="jcit_480"><au apt_id="481" id="au_481"><s title="Surname" apt_id="482" id="s_482">Zug</s><f title="First name" apt_id="483" id="f_483">R</f></au>, . <at title="Article Title" apt_id="484" id="at_484">Developmental disorders caused by haploinsufficiency of transcriptional regulators: a perspective based on cell fate determination</at>. <pt title="Periodical Title" apt_id="485" id="pt_485">Biol. Open</pt> <yr title="Year" apt_id="486" id="yr_486">2022</yr>;<v title="Volume" apt_id="487" id="v_487">11</v>:<pages title="Pages" apt_id="488" id="pages_488">bio058896</pages>. <url title="URL" type="uri" href="https://doi.org/10.1242/bio.058896" apt_id="489" id="url_489">https://doi.org/10.1242/bio.058896</url> </jcit></bib><bib type="arabic" id="bib_490" sno="3" suffix="." apt_id="490"><jcit apt_id="491" id="jcit_491"><au apt_id="492" id="au_492"><s title="Surname" apt_id="493" id="s_493">Matharu</s><f title="First name" apt_id="494" id="f_494">N</f></au>, <au apt_id="495" id="au_495"><s title="Surname" apt_id="496" id="s_496">Ahituv</s><f title="First name" apt_id="497" id="f_497">N</f></au>, . <at title="Article Title" apt_id="498" id="at_498">Modulating gene regulation to treat genetic disorders</at>. <pt title="Periodical Title" apt_id="499" id="pt_499">Nat Rev Drug Discov</pt> <yr title="Year" apt_id="500" id="yr_500">2020</yr>;<v title="Volume" apt_id="501" id="v_501">19</v>:<pages title="Pages" apt_id="502" id="pages_502">757–75</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/s41573-020-0083-7" apt_id="503" id="url_503">https://doi.org/10.1038/s41573-020-0083-7</url> </jcit></bib><bib type="arabic" id="bib_504" sno="4" suffix="." apt_id="504"><jcit apt_id="505" id="jcit_505"><au apt_id="506" id="au_506"><s title="Surname" apt_id="507" id="s_507">Wong</s><f title="First name" apt_id="508" id="f_508">LC</f></au>, <au apt_id="509" id="au_509"><s title="Surname" apt_id="510" id="s_510">Singh</s><f title="First name" apt_id="511" id="f_511">S</f></au>, <au apt_id="512" id="au_512"><s title="Surname" apt_id="513" id="s_513">Wang</s><f title="First name" apt_id="514" id="f_514">HP</f></au>, <etal title="etal" apt_id="515" id="etal_515">et al.</etal> <at title="Article Title" apt_id="516" id="at_516">FOXG1-Related syndrome: from clinical to molecular genetics and pathogenic mechanisms</at>. <pt title="Periodical Title" apt_id="517" id="pt_517">Int J Mol Sci</pt> <yr title="Year" apt_id="518" id="yr_518">2019</yr>;<v title="Volume" apt_id="519" id="v_519">20</v>. <url title="URL" type="uri" href="https://doi.org/10.3390/IJMS20174176" apt_id="520" id="url_520">https://doi.org/10.3390/IJMS20174176</url><query><button type="button" title="Copy Editor to Author-AU: Pages is missing in this reference [4]. Please provide, if available." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="22" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">22</span></button></query></jcit></bib><bib type="arabic" id="bib_523" sno="5" suffix="." apt_id="523"><jcit apt_id="524" id="jcit_524"><au apt_id="525" id="au_525"><s title="Surname" apt_id="526" id="s_526">Mitter</s><f title="First name" apt_id="527" id="f_527">D</f></au>, <au apt_id="528" id="au_528"><s title="Surname" apt_id="529" id="s_529">Pringsheim</s><f title="First name" apt_id="530" id="f_530">M</f></au>, <au apt_id="531" id="au_531"><s title="Surname" apt_id="532" id="s_532">Kaulisch</s><f title="First name" apt_id="533" id="f_533">M</f></au>, <etal title="etal" apt_id="534" id="etal_534">et al.</etal> <at title="Article Title" apt_id="535" id="at_535">FOXG1 Syndrome: genotype-phenotype association in 83 patients with FOXG1 variants</at>. <pt title="Periodical Title" apt_id="536" id="pt_536">Genet Med</pt> <yr title="Year" apt_id="537" id="yr_537">2018</yr>;<v title="Volume" apt_id="538" id="v_538">20</v>:<pages title="Pages" apt_id="539" id="pages_539">98–108</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/GIM.2017.75" apt_id="540" id="url_540">https://doi.org/10.1038/GIM.2017.75</url> </jcit></bib><bib type="arabic" id="bib_541" sno="6" suffix="." apt_id="541"><jcit apt_id="542" id="jcit_542"><au apt_id="543" id="au_543"><s title="Surname" apt_id="544" id="s_544">Vegas</s><f title="First name" apt_id="545" id="f_545">N</f></au>, <au apt_id="546" id="au_546"><s title="Surname" apt_id="547" id="s_547">Cavallin</s><f title="First name" apt_id="548" id="f_548">M</f></au>, <au apt_id="549" id="au_549"><s title="Surname" apt_id="550" id="s_550">Maillard</s><f title="First name" apt_id="551" id="f_551">C</f></au>, <etal title="etal" apt_id="552" id="etal_552">et al.</etal> <at title="Article Title" apt_id="553" id="at_553">Delineating FOXG1 syndrome: from congenital microcephaly to hyperkinetic encephalopathy</at>. <pt title="Periodical Title" apt_id="554" id="pt_554">Neurol Genet</pt> <yr title="Year" apt_id="555" id="yr_555">2018</yr>;<v title="Volume" apt_id="556" id="v_556">4</v>. <url title="URL" type="uri" href="https://doi.org/10.1212/NXG.0000000000000281" apt_id="557" id="url_557">https://doi.org/10.1212/NXG.0000000000000281</url> <query><button type="button" title="Copy Editor to Author-AU: Pages is missing in this reference [6]. Please provide, if available." contenteditable="false" query-type="open" roleid="12" froleid="12" troleid="14" conversation-uid="23" class="btn btn-outline-primary2 my-1 me-2 fw-bold btn-qry-reply" role="button">Q.<span class="badge" conversation-text="query">23</span></button></query></jcit></bib><bib type="arabic" id="bib_560" sno="7" suffix="." apt_id="560"><jcit apt_id="561" id="jcit_561"><au apt_id="562" id="au_562"><s title="Surname" apt_id="563" id="s_563">Mariani</s><f title="First name" apt_id="564" id="f_564">J</f></au>, <au apt_id="565" id="au_565"><s title="Surname" apt_id="566" id="s_566">Coppola</s><f title="First name" apt_id="567" id="f_567">G</f></au>, <au apt_id="568" id="au_568"><s title="Surname" apt_id="569" id="s_569">Zhang</s><f title="First name" apt_id="570" id="f_570">P</f></au>, <etal title="etal" apt_id="571" id="etal_571">et al.</etal> <at title="Article Title" apt_id="572" id="at_572">FOXG1-Dependent dysregulation of GABA/glutamate neuron differentiation in Autism spectrum disorders</at>. <pt title="Periodical Title" apt_id="573" id="pt_573">Cell</pt> <yr title="Year" apt_id="574" id="yr_574">2015</yr>;<v title="Volume" apt_id="575" id="v_575">162</v>:<pages title="Pages" apt_id="576" id="pages_576">375–90</pages>. <url title="URL" type="uri" href="https://doi.org/10.1016/j.cell.2015.06.034" apt_id="577" id="url_577">https://doi.org/10.1016/j.cell.2015.06.034</url> </jcit></bib><bib type="arabic" id="bib_578" sno="8" suffix="." apt_id="578"><jcit apt_id="579" id="jcit_579"><au apt_id="580" id="au_580"><s title="Surname" apt_id="581" id="s_581">Testa</s><f title="First name" apt_id="582" id="f_582">G</f></au>, <au apt_id="583" id="au_583"><s title="Surname" apt_id="584" id="s_584">Olimpico</s><f title="First name" apt_id="585" id="f_585">F</f></au>, <au apt_id="586" id="au_586"><s title="Surname" apt_id="587" id="s_587">Pancrazi</s><f title="First name" apt_id="588" id="f_588">L</f></au>, <etal title="etal" apt_id="589" id="etal_589">et al.</etal> <at title="Article Title" apt_id="590" id="at_590">Cortical seizures in FoxG1± mice are accompanied by Akt/S6 overactivation, excitation/inhibition imbalance and impaired synaptic transmission</at>. <pt title="Periodical Title" apt_id="591" id="pt_591">Int J Mol Sci</pt> <yr title="Year" apt_id="592" id="yr_592">2019</yr>;<v title="Volume" apt_id="593" id="v_593">20</v>:<pages title="Pages" apt_id="594" id="pages_594">E4127</pages>. <url title="URL" type="uri" href="https://doi.org/10.3390/ijms20174127" apt_id="595" id="url_595">https://doi.org/10.3390/ijms20174127</url></jcit></bib><bib type="arabic" id="bib_596" sno="9" suffix="." apt_id="596"><jcit apt_id="597" id="jcit_597"><au apt_id="598" id="au_598"><s title="Surname" apt_id="599" id="s_599">Wang</s><f title="First name" apt_id="600" id="f_600">L</f></au>, <au apt_id="601" id="au_601"><s title="Surname" apt_id="602" id="s_602">Wang</s><f title="First name" apt_id="603" id="f_603">J</f></au>, <au apt_id="604" id="au_604"><s title="Surname" apt_id="605" id="s_605">Jin</s><f title="First name" apt_id="606" id="f_606">T</f></au>, <etal title="etal" apt_id="607" id="etal_607">et al.</etal> <at title="Article Title" apt_id="608" id="at_608">FoxG1 Facilitates proliferation and inhibits differentiation by downregulating FoxO/smad signaling in glioblastoma</at>. <pt title="Periodical Title" apt_id="609" id="pt_609">Biochem Biophys Res Commun</pt> <yr title="Year" apt_id="610" id="yr_610">2018</yr>;<v title="Volume" apt_id="611" id="v_611">504</v>:<pages title="Pages" apt_id="612" id="pages_612">46–53</pages>. <url title="URL" type="uri" href="https://doi.org/10.1016/j.bbrc.2018.08.118" apt_id="613" id="url_613">https://doi.org/10.1016/j.bbrc.2018.08.118</url> </jcit></bib><bib type="arabic" id="bib_614" sno="10" suffix="." apt_id="614"><jcit apt_id="615" id="jcit_615"><au apt_id="616" id="au_616"><s title="Surname" apt_id="617" id="s_617">Brancaccio</s><f title="First name" apt_id="618" id="f_618">M</f></au>, <au apt_id="619" id="au_619"><s title="Surname" apt_id="620" id="s_620">Pivetta</s><f title="First name" apt_id="621" id="f_621">C</f></au>, <au apt_id="622" id="au_622"><s title="Surname" apt_id="623" id="s_623">Granzotto</s><f title="First name" apt_id="624" id="f_624">M</f></au>, <etal title="etal" apt_id="625" id="etal_625">et al.</etal> <at title="Article Title" apt_id="626" id="at_626">Emx2 and Foxg1 inhibit gliogenesis and promote neuronogenesis</at>. <pt title="Periodical Title" apt_id="627" id="pt_627">Stem Cells Dayt. Ohio</pt> <yr title="Year" apt_id="628" id="yr_628">2010</yr>;<v title="Volume" apt_id="629" id="v_629">28</v>:<pages title="Pages" apt_id="630" id="pages_630">1206–18</pages>. <url title="URL" type="uri" href="https://doi.org/10.1002/stem.443" apt_id="631" id="url_631">https://doi.org/10.1002/stem.443</url></jcit></bib><bib type="arabic" id="bib_632" sno="11" suffix="." apt_id="632"><jcit apt_id="633" id="jcit_633"><au apt_id="634" id="au_634"><s title="Surname" apt_id="635" id="s_635">Miyoshi</s><f title="First name" apt_id="636" id="f_636">G</f></au>, <au apt_id="637" id="au_637"><s title="Surname" apt_id="638" id="s_638">Ueta</s><f title="First name" apt_id="639" id="f_639">Y</f></au>, <au apt_id="640" id="au_640"><s title="Surname" apt_id="641" id="s_641">Natsubori</s><f title="First name" apt_id="642" id="f_642">A</f></au>, <etal title="etal" apt_id="643" id="etal_643">et al.</etal> <at title="Article Title" apt_id="644" id="at_644">FoxG1 Regulates the formation of cortical GABAergic circuit during an early postnatal critical period resulting in Autism spectrum disorder-like phenotypes</at>. <pt title="Periodical Title" apt_id="645" id="pt_645">Nat Commun</pt> <yr title="Year" apt_id="646" id="yr_646">2021</yr>;<v title="Volume" apt_id="647" id="v_647">12</v>:<pages title="Pages" apt_id="648" id="pages_648">3773</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/s41467-021-23987-z" apt_id="649" id="url_649">https://doi.org/10.1038/s41467-021-23987-z</url> </jcit></bib><bib type="arabic" id="bib_650" sno="12" suffix="." apt_id="650"><jcit apt_id="651" id="jcit_651"><au apt_id="652" id="au_652"><s title="Surname" apt_id="653" id="s_653">Akol</s><f title="First name" apt_id="654" id="f_654">I</f></au>, <au apt_id="655" id="au_655"><s title="Surname" apt_id="656" id="s_656">Gather</s><f title="First name" apt_id="657" id="f_657">F</f></au>, <au apt_id="658" id="au_658"><s title="Surname" apt_id="659" id="s_659">Vogel</s><f title="First name" apt_id="660" id="f_660">T</f></au>, . <at title="Article Title" apt_id="661" id="at_661">Paving therapeutic avenues for FOXG1 syndrome: untangling genotypes and phenotypes from a molecular perspective</at>. <pt title="Periodical Title" apt_id="662" id="pt_662">Int J Mol Sci</pt> <yr title="Year" apt_id="663" id="yr_663">2022</yr>;<v title="Volume" apt_id="664" id="v_664">23</v>:<pages title="Pages" apt_id="665" id="pages_665">954</pages>. <url title="URL" type="uri" href="https://doi.org/10.3390/ijms23020954" apt_id="666" id="url_666">https://doi.org/10.3390/ijms23020954</url> </jcit></bib><bib type="arabic" id="bib_667" sno="13" suffix="." apt_id="667"><jcit apt_id="668" id="jcit_668"><au apt_id="669" id="au_669"><s title="Surname" apt_id="670" id="s_670">Yu</s><f title="First name" apt_id="671" id="f_671">B</f></au>, <au apt_id="672" id="au_672"><s title="Surname" apt_id="673" id="s_673">Liu</s><f title="First name" apt_id="674" id="f_674">J</f></au>, <au apt_id="675" id="au_675"><s title="Surname" apt_id="676" id="s_676">Su</s><f title="First name" apt_id="677" id="f_677">M</f></au>, <etal title="etal" apt_id="678" id="etal_678">et al.</etal> <at title="Article Title" apt_id="679" id="at_679">Disruption of Foxg1 impairs neural plasticity leading to social and cognitive behavioral defects</at>. <pt title="Periodical Title" apt_id="680" id="pt_680">Mol Brain</pt> <yr title="Year" apt_id="681" id="yr_681">2019</yr>;<v title="Volume" apt_id="682" id="v_682">12</v>:<pages title="Pages" apt_id="683" id="pages_683">63</pages>. <url title="URL" type="uri" href="https://doi.org/10.1186/s13041-019-0484-x" apt_id="684" id="url_684">https://doi.org/10.1186/s13041-019-0484-x</url> </jcit></bib><bib type="arabic" id="bib_685" sno="14" suffix="." apt_id="685"><jcit apt_id="686" id="jcit_686"><au apt_id="687" id="au_687"><s title="Surname" apt_id="688" id="s_688">Kuzmin</s><f title="First name" apt_id="689" id="f_689">DA</f></au>, <au apt_id="690" id="au_690"><s title="Surname" apt_id="691" id="s_691">Shutova</s><f title="First name" apt_id="692" id="f_692">MV</f></au>, <au apt_id="693" id="au_693"><s title="Surname" apt_id="694" id="s_694">Johnston</s><f title="First name" apt_id="695" id="f_695">NR</f></au>, <etal title="etal" apt_id="696" id="etal_696">et al.</etal> <at title="Article Title" apt_id="697" id="at_697">The clinical landscape for AAV gene therapies</at>. <pt title="Periodical Title" apt_id="698" id="pt_698">Nat Rev Drug Discov</pt> <yr title="Year" apt_id="699" id="yr_699">2021</yr>;<v title="Volume" apt_id="700" id="v_700">20</v>:<pages title="Pages" apt_id="701" id="pages_701">173–4</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/d41573-021-00017-7" apt_id="702" id="url_702">https://doi.org/10.1038/d41573-021-00017-7</url> </jcit></bib><bib type="arabic" id="bib_703" sno="15" suffix="." apt_id="703"><jcit apt_id="704" id="jcit_704"><au apt_id="705" id="au_705"><s title="Surname" apt_id="706" id="s_706">Matharu</s><f title="First name" apt_id="707" id="f_707">N</f></au>, <au apt_id="708" id="au_708"><s title="Surname" apt_id="709" id="s_709">Rattanasopha</s><f title="First name" apt_id="710" id="f_710">S</f></au>, <au apt_id="711" id="au_711"><s title="Surname" apt_id="712" id="s_712">Tamura</s><f title="First name" apt_id="713" id="f_713">S</f></au>, <etal title="etal" apt_id="714" id="etal_714">et al.</etal> <at title="Article Title" apt_id="715" id="at_715">CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency</at>. <pt title="Periodical Title" apt_id="716" id="pt_716">Science</pt> <yr title="Year" apt_id="717" id="yr_717">2019</yr>;<v title="Volume" apt_id="718" id="v_718">363</v>:<pages title="Pages" apt_id="719" id="pages_719">eaau0629</pages>. <url title="URL" type="uri" href="https://doi.org/10.1126/science.aau0629" apt_id="720" id="url_720">https://doi.org/10.1126/science.aau0629</url> </jcit></bib><bib type="arabic" id="bib_721" sno="16" suffix="." apt_id="721"><jcit apt_id="722" id="jcit_722"><au apt_id="723" id="au_723"><s title="Surname" apt_id="724" id="s_724">Horlbeck</s><f title="First name" apt_id="725" id="f_725">MA</f></au>, <au apt_id="726" id="au_726"><s title="Surname" apt_id="727" id="s_727">Gilbert</s><f title="First name" apt_id="728" id="f_728">LA</f></au>, <au apt_id="729" id="au_729"><s title="Surname" apt_id="730" id="s_730">Villalta</s><f title="First name" apt_id="731" id="f_731">JE</f></au>, <etal title="etal" apt_id="732" id="etal_732">et al.</etal> <at title="Article Title" apt_id="733" id="at_733">Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation</at>. <pt title="Periodical Title" apt_id="734" id="pt_734">eLife</pt> <yr title="Year" apt_id="735" id="yr_735">2016</yr>;<v title="Volume" apt_id="736" id="v_736">5</v>:<pages title="Pages" apt_id="737" id="pages_737">e19760</pages>. <url title="URL" type="uri" href="https://doi.org/10.7554/eLife.19760" apt_id="738" id="url_738">https://doi.org/10.7554/eLife.19760</url> </jcit></bib><bib type="arabic" id="bib_739" sno="17" suffix="." apt_id="739"><jcit apt_id="740" id="jcit_740"><au apt_id="741" id="au_741"><s title="Surname" apt_id="742" id="s_742">Montague</s><f title="First name" apt_id="743" id="f_743">TG</f></au>, <au apt_id="744" id="au_744"><s title="Surname" apt_id="745" id="s_745">Cruz</s><f title="First name" apt_id="746" id="f_746">JM</f></au>, <au apt_id="747" id="au_747"><s title="Surname" apt_id="748" id="s_748">Gagnon</s><f title="First name" apt_id="749" id="f_749">JA</f></au>, <etal title="etal" apt_id="750" id="etal_750">et al.</etal> <at title="Article Title" apt_id="751" id="at_751">CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing</at>. <pt title="Periodical Title" apt_id="752" id="pt_752">Nucleic Acids Res.</pt> <yr title="Year" apt_id="753" id="yr_753">2014</yr>;<v title="Volume" apt_id="754" id="v_754">42</v>:<pages title="Pages" apt_id="755" id="pages_755">W401–7</pages>. <url title="URL" type="uri" href="https://doi.org/10.1093/nar/gku410" apt_id="756" id="url_756">https://doi.org/10.1093/nar/gku410</url> </jcit></bib><bib type="arabic" id="bib_757" sno="18" suffix="." apt_id="757"><jcit apt_id="758" id="jcit_758"><au apt_id="759" id="au_759"><s title="Surname" apt_id="760" id="s_760">Mali</s><f title="First name" apt_id="761" id="f_761">P</f></au>, <au apt_id="762" id="au_762"><s title="Surname" apt_id="763" id="s_763">Yang</s><f title="First name" apt_id="764" id="f_764">L</f></au>, <au apt_id="765" id="au_765"><s title="Surname" apt_id="766" id="s_766">Esvelt</s><f title="First name" apt_id="767" id="f_767">KM</f></au>, <etal title="etal" apt_id="768" id="etal_768">et al.</etal> <at title="Article Title" apt_id="769" id="at_769">RNA-guided Human genome engineering via Cas9</at>. <pt title="Periodical Title" apt_id="770" id="pt_770">Science</pt> <yr title="Year" apt_id="771" id="yr_771">2013</yr>;<v title="Volume" apt_id="772" id="v_772">339</v>:<pages title="Pages" apt_id="773" id="pages_773">823–6</pages>. <url title="URL" type="uri" href="https://doi.org/10.1126/science.1232033" apt_id="774" id="url_774">https://doi.org/10.1126/science.1232033</url> </jcit></bib><bib type="arabic" id="bib_775" sno="19" suffix="." apt_id="775"><jcit apt_id="776" id="jcit_776"><au apt_id="777" id="au_777"><s title="Surname" apt_id="778" id="s_778">Truong</s><f title="First name" apt_id="779" id="f_779">D-JJ</f></au>, <au apt_id="780" id="au_780"><s title="Surname" apt_id="781" id="s_781">Kühner</s><f title="First name" apt_id="782" id="f_782">K</f></au>, <au apt_id="783" id="au_783"><s title="Surname" apt_id="784" id="s_784">Kühn</s><f title="First name" apt_id="785" id="f_785">R</f></au>, <etal title="etal" apt_id="786" id="etal_786">et al.</etal> <at title="Article Title" apt_id="787" id="at_787">Development of an intein-mediated split-Cas9 system for gene therapy</at>. <pt title="Periodical Title" apt_id="788" id="pt_788">Nucleic Acids Res</pt> <yr title="Year" apt_id="789" id="yr_789">2015</yr>;<v title="Volume" apt_id="790" id="v_790">43</v>:<pages title="Pages" apt_id="791" id="pages_791">6450–8</pages>. <url title="URL" type="uri" href="https://doi.org/10.1093/nar/gkv601" apt_id="792" id="url_792">https://doi.org/10.1093/nar/gkv601</url> </jcit></bib><bib type="arabic" id="bib_793" sno="20" suffix="." apt_id="793"><jcit apt_id="794" id="jcit_794"><au apt_id="795" id="au_795"><s title="Surname" apt_id="796" id="s_796">Chew</s><f title="First name" apt_id="797" id="f_797">WL</f></au>, <au apt_id="798" id="au_798"><s title="Surname" apt_id="799" id="s_799">Tabebordbar</s><f title="First name" apt_id="800" id="f_800">M</f></au>, <au apt_id="801" id="au_801"><s title="Surname" apt_id="802" id="s_802">Cheng</s><f title="First name" apt_id="803" id="f_803">JKW</f></au>, <etal title="etal" apt_id="804" id="etal_804">et al.</etal> <at title="Article Title" apt_id="805" id="at_805">A multifunctional AAV-CRISPR-Cas9 and its host response</at>. <pt title="Periodical Title" apt_id="806" id="pt_806">Nat Methods</pt> <yr title="Year" apt_id="807" id="yr_807">2016</yr>;<v title="Volume" apt_id="808" id="v_808">13</v>:<pages title="Pages" apt_id="809" id="pages_809">868–74</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/nmeth.3993" apt_id="810" id="url_810">https://doi.org/10.1038/nmeth.3993</url> </jcit></bib><bib type="arabic" id="bib_811" sno="21" suffix="." apt_id="811"><jcit apt_id="812" id="jcit_812"><au apt_id="813" id="au_813"><s title="Surname" apt_id="814" id="s_814">Fine</s><f title="First name" apt_id="815" id="f_815">EJ</f></au>, <au apt_id="816" id="au_816"><s title="Surname" apt_id="817" id="s_817">Appleton</s><f title="First name" apt_id="818" id="f_818">CM</f></au>, <au apt_id="819" id="au_819"><s title="Surname" apt_id="820" id="s_820">White</s><f title="First name" apt_id="821" id="f_821">DE</f></au>, <etal title="etal" apt_id="822" id="etal_822">et al.</etal> <at title="Article Title" apt_id="823" id="at_823">Trans-spliced Cas9 allows cleavage of HBB and CCR5 genes in Human cells using compact expression cassettes</at>. <pt title="Periodical Title" apt_id="824" id="pt_824">Sci Rep</pt> <yr title="Year" apt_id="825" id="yr_825">2015</yr>;<v title="Volume" apt_id="826" id="v_826">5</v>:<pages title="Pages" apt_id="827" id="pages_827">10777</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/srep10777" apt_id="828" id="url_828">https://doi.org/10.1038/srep10777</url> </jcit></bib><bib type="arabic" id="bib_829" sno="22" suffix="." apt_id="829"><jcit apt_id="830" id="jcit_830"><au apt_id="831" id="au_831"><s title="Surname" apt_id="832" id="s_832">Hilton</s><f title="First name" apt_id="833" id="f_833">IB</f></au>, <au apt_id="834" id="au_834"><s title="Surname" apt_id="835" id="s_835">D’Ippolito</s><f title="First name" apt_id="836" id="f_836">AM</f></au>, <au apt_id="837" id="au_837"><s title="Surname" apt_id="838" id="s_838">Vockley</s><f title="First name" apt_id="839" id="f_839">CM</f></au>, <etal title="etal" apt_id="840" id="etal_840">et al.</etal> <at title="Article Title" apt_id="841" id="at_841">Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers</at>. <pt title="Periodical Title" apt_id="842" id="pt_842">Nat Biotechnol</pt> <yr title="Year" apt_id="843" id="yr_843">2015</yr>;<v title="Volume" apt_id="844" id="v_844">33</v>:<pages title="Pages" apt_id="845" id="pages_845">510–7</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/nbt.3199" apt_id="846" id="url_846">https://doi.org/10.1038/nbt.3199</url> </jcit></bib><bib type="arabic" id="bib_847" sno="23" suffix="." apt_id="847"><jcit apt_id="848" id="jcit_848"><au apt_id="849" id="au_849"><s title="Surname" apt_id="850" id="s_850">Maeder</s><f title="First name" apt_id="851" id="f_851">ML</f></au>, <au apt_id="852" id="au_852"><s title="Surname" apt_id="853" id="s_853">Linder</s><f title="First name" apt_id="854" id="f_854">SJ</f></au>, <au apt_id="855" id="au_855"><s title="Surname" apt_id="856" id="s_856">Cascio</s><f title="First name" apt_id="857" id="f_857">VM</f></au>, <etal title="etal" apt_id="858" id="etal_858">et al.</etal> <at title="Article Title" apt_id="859" id="at_859">CRISPR RNA-guided activation of endogenous Human genes</at>. <pt title="Periodical Title" apt_id="860" id="pt_860">Nat Methods</pt> <yr title="Year" apt_id="861" id="yr_861">2013</yr>;<v title="Volume" apt_id="862" id="v_862">10</v>:<pages title="Pages" apt_id="863" id="pages_863">977–9</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/nmeth.2598" apt_id="864" id="url_864">https://doi.org/10.1038/nmeth.2598</url> </jcit></bib><bib type="arabic" id="bib_865" sno="24" suffix="." apt_id="865"><jcit apt_id="866" id="jcit_866"><au apt_id="867" id="au_867"><s title="Surname" apt_id="868" id="s_868">Konermann</s><f title="First name" apt_id="869" id="f_869">S</f></au>, <au apt_id="870" id="au_870"><s title="Surname" apt_id="871" id="s_871">Brigham</s><f title="First name" apt_id="872" id="f_872">MD</f></au>, <au apt_id="873" id="au_873"><s title="Surname" apt_id="874" id="s_874">Trevino</s><f title="First name" apt_id="875" id="f_875">AE</f></au>, <etal title="etal" apt_id="876" id="etal_876">et al.</etal> <at title="Article Title" apt_id="877" id="at_877">Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex</at>. <pt title="Periodical Title" apt_id="878" id="pt_878">Nature</pt> <yr title="Year" apt_id="879" id="yr_879">2015</yr>;<v title="Volume" apt_id="880" id="v_880">517</v>:<pages title="Pages" apt_id="881" id="pages_881">583–8</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/nature14136" apt_id="882" id="url_882">https://doi.org/10.1038/nature14136</url> </jcit></bib><bib type="arabic" id="bib_883" sno="25" suffix="." apt_id="883"><jcit apt_id="884" id="jcit_884"><au apt_id="885" id="au_885"><s title="Surname" apt_id="886" id="s_886">Chavez</s><f title="First name" apt_id="887" id="f_887">A</f></au>, <au apt_id="888" id="au_888"><s title="Surname" apt_id="889" id="s_889">Scheiman</s><f title="First name" apt_id="890" id="f_890">J</f></au>, <au apt_id="891" id="au_891"><s title="Surname" apt_id="892" id="s_892">Vora</s><f title="First name" apt_id="893" id="f_893">S</f></au>, <etal title="etal" apt_id="894" id="etal_894">et al.</etal> <at title="Article Title" apt_id="895" id="at_895">Highly efficient Cas9-mediated transcriptional programming</at>. <pt title="Periodical Title" apt_id="896" id="pt_896">Nat Methods</pt> <yr title="Year" apt_id="897" id="yr_897">2015</yr>;<v title="Volume" apt_id="898" id="v_898">12</v>:<pages title="Pages" apt_id="899" id="pages_899">326–8</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/nmeth.3312" apt_id="900" id="url_900">https://doi.org/10.1038/nmeth.3312</url> </jcit></bib><bib type="arabic" id="bib_901" sno="26" suffix="." apt_id="901"><jcit apt_id="902" id="jcit_902"><au apt_id="903" id="au_903"><s title="Surname" apt_id="904" id="s_904">Bae</s><f title="First name" apt_id="905" id="f_905">S</f></au>, <au apt_id="906" id="au_906"><s title="Surname" apt_id="907" id="s_907">Park</s><f title="First name" apt_id="908" id="f_908">J</f></au>, <au apt_id="909" id="au_909"><s title="Surname" apt_id="910" id="s_910">Kim</s><f title="First name" apt_id="911" id="f_911">J-S</f></au>, . <at title="Article Title" apt_id="912" id="at_912">Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases</at>. <pt title="Periodical Title" apt_id="913" id="pt_913">Bioinformatics</pt> <yr title="Year" apt_id="914" id="yr_914">2014</yr>;<v title="Volume" apt_id="915" id="v_915">30</v>:<pages title="Pages" apt_id="916" id="pages_916">1473–5</pages>. <url title="URL" type="uri" href="https://doi.org/10.1093/bioinformatics/btu048" apt_id="917" id="url_917">https://doi.org/10.1093/bioinformatics/btu048</url> </jcit></bib><bib type="arabic" id="bib_918" sno="27" suffix="." apt_id="918"><jcit apt_id="919" id="jcit_919"><au apt_id="920" id="au_920"><s title="Surname" apt_id="921" id="s_921">Frisari</s><f title="First name" apt_id="922" id="f_922">S</f></au>, <au apt_id="923" id="au_923"><s title="Surname" apt_id="924" id="s_924">Santo</s><f title="First name" apt_id="925" id="f_925">M</f></au>, <au apt_id="926" id="au_926"><s title="Surname" apt_id="927" id="s_927">Hosseini</s><f title="First name" apt_id="928" id="f_928">A</f></au>, <etal title="etal" apt_id="929" id="etal_929">et al.</etal> <at title="Article Title" apt_id="930" id="at_930">Multidimensional functional profiling of Human neuropathogenic FOXG1 alleles in primary cultures of murine pallial precursors</at>. <pt title="Periodical Title" apt_id="931" id="pt_931">Int J Mol Sci</pt> <yr title="Year" apt_id="932" id="yr_932">2022</yr>;<v title="Volume" apt_id="933" id="v_933">23</v>:<pages title="Pages" apt_id="934" id="pages_934">1343</pages>. <url title="URL" type="uri" href="https://doi.org/10.3390/ijms23031343" apt_id="935" id="url_935">https://doi.org/10.3390/ijms23031343</url> </jcit></bib><bib type="arabic" id="bib_936" sno="28" suffix="." apt_id="936"><jcit apt_id="937" id="jcit_937"><au apt_id="938" id="au_938"><s title="Surname" apt_id="939" id="s_939">Chavez</s><f title="First name" apt_id="940" id="f_940">A</f></au>, <au apt_id="941" id="au_941"><s title="Surname" apt_id="942" id="s_942">Tuttle</s><f title="First name" apt_id="943" id="f_943">M</f></au>, <au apt_id="944" id="au_944"><s title="Surname" apt_id="945" id="s_945">Pruitt</s><f title="First name" apt_id="946" id="f_946">BW</f></au>, <etal title="etal" apt_id="947" id="etal_947">et al.</etal> <at title="Article Title" apt_id="948" id="at_948">Comparison of Cas9 activators in multiple species</at>. <pt title="Periodical Title" apt_id="949" id="pt_949">Nat Methods</pt> <yr title="Year" apt_id="950" id="yr_950">2016</yr>;<v title="Volume" apt_id="951" id="v_951">13</v>:<pages title="Pages" apt_id="952" id="pages_952">563–7</pages>. <url title="URL" type="uri" href="https://doi.org/10.1038/nmeth.3871" apt_id="953" id="url_953">https://doi.org/10.1038/nmeth.3871</url> </jcit></bib><bib type="arabic" id="bib_954" sno="29" suffix="." apt_id="954"><jcit apt_id="955" id="jcit_955"><au apt_id="956" id="au_956"><s title="Surname" apt_id="957" id="s_957">He</s><f title="First name" apt_id="958" id="f_958">Z-H</f></au>, <au apt_id="959" id="au_959"><s title="Surname" apt_id="960" id="s_960">Zou</s><f title="First name" apt_id="961" id="f_961">S-Y</f></au>, <au apt_id="962" id="au_962"><s title="Surname" apt_id="963" id="s_963">Li</s><f title="First name" apt_id="964" id="f_964">M</f></au>, <etal title="etal" apt_id="965" id="etal_965">et al.</etal> <at title="Article Title" apt_id="966" id="at_966">The nuclear transcription factor FoxG1 affects the sensitivity of mimetic aging hair cells to inflammation by regulating autophagy pathways</at>. <pt title="Periodical Title" apt_id="967" id="pt_967">Redox Biol</pt> <yr title="Year" apt_id="968" id="yr_968">2020</yr>;<v title="Volume" apt_id="969" id="v_969">28</v>:<pages title="Pages" apt_id="970" id="pages_970">101364</pages>. <url title="URL" type="uri" href="https://doi.org/10.1016/j.redox.2019.101364" apt_id="971" id="url_971">https://doi.org/10.1016/j.redox.2019.101364</url> </jcit></bib></ref></bm></doc>